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Abstract 
Cell-free expression systems are widely used to synthesize proteins for subsequent further 
characterization, to manufacture potentially useful commercial end products, and to 
construct cellular mimics in the laboratory. The first part of the thesis explores the 
feasibility of preparing two of the commercially available and widely used E. coli-based 
cell-free expression systems: the PURE System and the S30 Bacterial Extract. The second 
part focuses on the characterization of in vitro transcription and translation. The third part 
of the thesis features an example of an application of S30 Bacterial Extract cell-free 
expression systems i.e. the building of cell-like structures that can work together with 
engineered bacteria to achieve a predetermined task. Finally, the construction of a 
microfluidic dialysis device compatible with cell-free synthetic biology projects is 
presented. 
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Introduction 
The regulation and control of living systems behavior have always represented a major 
concern and interest for mankind. Some of the most crucial steps in the development of 
modern society are due to the successful control of biological entities neighboring the 
human beings, see the outbreak of agriculture and livestock breeding. More sophisticated 
techniques for the control of living systems have evolved together with the increase of 
knowledge of the systems themselves. As an example, understanding how plants work 
allowed to develop grafting procedures for the creation of more productive and resistant 
cultivars and crossbreeding was introduced to obtain the same result for livestock.  
With the beginning of the biotechnology era, the control of living systems 
deepened to the cellular level. Attempts to control cellular behavior are mainly based on 
genetic engineering. This approach is definitely useful and allows to achieve 
unprecedented results. Nevertheless, a comprehensive and ample understanding on how 
living cell function is far to be fully achieved. This knowledge limitation may translate in 
the arise of unwanted or unexpected traits since living cells can grow, evolve and 
eventually modify the engineered circuits. The creation of completely new entities with 
only specific and desired cell functions would lead to controlled and programmable 
cellular mimics, a solution to the unpredictability of engineered natural systems. Natural 
cells regulate their behavior by sensing and responding to the surrounding environmental 
changes and to other cells signaling. Artificial systems can be built and designed to 
interact with natural communication pathways with the desired result of taking active part 
in cellular communication and effectively modify cellular behavior. Moreover, attempts 
to modify behavior of cells through the mimicking of natural communication may lead to 
a better understanding of how such systems function. Two main approaches are employed 
for the synthesis of artificial cells, top-down and bottom-up. The top-down approach aims 
to achieve a minimal system driven by an essential gene set by depleting unwanted 
functions from pre-existing cells. The bottom-up approach starts with the creation of a 
cell-like system from minimal non-living components. The resulting artificial cell 
consists of the basic elements that are usually associated with natural cells, such as i) a 
compartment for the isolation of the interior from the surrounding environment, ii) 
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information about the function of the system, usually encoded into nucleic acids, iii) a 
machinery that can interpret the information and translate it into a desired output. 
This work focuses on cell-free protein expression systems which may constitute 
the interior machinery of artificial cells. Cell-free protein expression systems can be 
prepared in different ways and can be based on diverse host organism but share the 
common feature of lacking the host genetic information. The desired function can be 
given to an artificial cell by encapsulating cell-free protein expression system provided 
with a specific template, thus allowing for the synthesis of one or more desired proteins. 
The first chapter focuses on the exploration of two of the most popular E. coli 
based cell-free expression systems. These systems were prepared in the lab and tested for 
activity. Here, an attempt to reconstitute the PURE, a contaminant-free system built with 
purified components only, is presented and the successful reconstitution of E. coli S30 
Extract is shown. In the second chapter cell-free expression systems are used to 
characterize in vitro transcription and translation. The work presented provides evidences 
that in vitro translation is more variable than transcription and that this is at least partially 
due to the higher system complexity of translation compared to transcription and the GC 
content and mRNA. The third chapter describes one step towards the establishment of 
artificial cells communities. A known issue of artificial cells is the depletion of energy 
resources which constitutes a limitation in the lasting and efficacy of such systems. Here, 
is presented the characterization of one step of a proposed network of artificial and 
engineered cells, for the proof-of-concept that energy-expensive tasks could be eventually 
completed by a consortium of different artificial cells. The last chapter of the thesis 
presents the construction of a microfluidics dialysis device. The preparation of a part of 
the platform was characterized and the resulting platform was used to perform and 
monitor chemical communication among engineered bacteria and among cell-free 
reactions. The dialysis chip could eventually be exploited for testing and prototyping 
genetic circuits for cell-free protein expression systems of for the characterization of 
uncultured microorganisms.  
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Chapter 1.  
Homemade cell-free expression systems 
1.1. Introduction 
One of the most important discoveries in molecular biology was that lysates from 
shredded bacteria or cells could still provide evidences of occurring protein synthesis. 
Rapidly, cell-free or in vitro protein synthesis systems were developed by removal of the 
heavier components by centrifugation at 30,000 xg, the S30 Extracts. 
 The first reports of cell-free protein synthesis were mainly studies of the 
mechanisms at the core of translation. The investigation of how amino acids are 
incorporated into nascent polypeptides was indeed tackled in the early 50s and mostly 
featured cell-free expression systems based on different organisms. Among the others, 
systems based on rat liver cells1, bacteria2,3, human and rabbit reticulocites4,5 allowed for 
the discovery of the key role of ribosomes and the ATP- and GTP-dependent operation 
of protein synthesis6,7. At that time, designing protein expression experiments with cell-
free systems was more appealing than working in vivo, as recombinant DNA technologies 
and genetic engineering protocols were not available until some decades later8,9. One of 
the most remarkable achievements using cell-free expression systems was the finding of 
amino acids codification in nucleotide triplets. In 1961 Nirenberg and Matthaei, awarded 
with the Nobel Prize in Medicine a few years later, demonstrated cell-free synthesis of 
polyphenylalanine from synthetic polyuridylic acid in the E. coli extract10. Described in 
this work there is also one of the first reports of translation of exogenous message after 
the removal of all endogenous mRNA.  
As a result of the breakout of recombinant DNA tools, cell-free expression lost 
part of the attention and working in vivo using cellular or bacterial hosts became 
prevalent, both for basic research and for protein production. Exception was made for 
some application niches in which in vitro protein synthesis was still preferred, for 
example for the production of hard-to-express proteins such as antibodies11,12 or cytotoxic 
proteins13,14. Despite the predominance of in vivo technologies in terms of scale and ease 
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of procedures, another major step was taken towards more efficient in vitro systems. The 
introduction of coupled transcription-translation cell-free systems allowed to prime the 
protein production reaction with DNA, rather than using mRNA15. This breakthrough not 
only simplified the protocol, bypassing the initial in vitro transcription step, but also 
opened new possibilities for the study of gene regulation.  
Innovation continued with the introduction of heterologous systems which 
combined the high processivity of bacteriophage RNA polymerases with the previously 
mentioned translation machineries. SP6 RNA polymerase and T7 RNA polymerase16,17 
were employed for driving the specific transcription of genes placed behind the 
correspondent promoter with several advantages. In bacteria-based extract, the selective 
inhibition of endogenous RNA polymerase by the addition of rifampicin18 allows for 
highly selective expression of the protein of interest. Moreover, the mRNA levels 
provided by phage RNA polymerases are higher than the ones obtained with endogenous 
polymerases19.  
 In 2001, the issues related to inhibitory factors and residual synthesis of non-
specific endogenous proteins were addressed by the Ueda group with the creation of the 
PURE system (Protein synthesis Using Recombinant Elements)20. The PURE system 
features i) the full set of components required for efficient protein synthesis i.e the 20 
tRNA synthetases (ARSs), 3 translation initiation factors (IF1, IF2, and IF3), 3 translation 
elongation factors (EF-G, EF-Tu, and EFTs), 3 translation termination factors (RF1, RF2, 
and RF3), methionyl-tRNA transformylase (MTF), T7 RNA polymerase, and ribosomes; 
ii) the substrate molecules needed for efficient transcription and translation reactions to 
occur i.e. 46 transfer RNAs (tRNAs), ribonucleotides (NTPs), 10-formyl-5,6,7,8-
tetrahydrofolic acid (folinic acid) and 20 amino acids; iii) an energy storage system based 
on ATP regeneration and side products disposal i.e. creatine phosphate, creatine kinase, 
myokinase, nucleoside-diphosphate kinase, and pyrophosphatase.  
The PURE system, free of unnecessary cellular components, facilitates in vitro 
studies thanks to a much cleaner background than a lysate-based system. The absence of 
nucleases ensures a higher stability of the DNA template and the mRNA, allowing the 
use of linear DNA templates. The PURE system showed to fit the needs of in vitro protein 
engineering21 and performed well in such in vitro applications as mRNA display22 and 
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ribosome display23,24. The highly controlled content of the system allows also for its 
customization for the expression of proteins which require particular folding conditions. 
The addition of glutathione, disulfide isomerase and chaperons to the system specifically 
meant for protein disulfide bonds enhancement21,25 whereas the implementation with 
membrane integration/translocation systems led to the successful expression and folding 
of integral membrane proteins26. Another well-covered advantage in using the PURE 
system is the possibility to omit one of the release factors (RF1) for the incorporation of 
un-natural amino acids at specific amber codon sites (UAG) using chemically mis-
acylated suppressor tRNA20,27–29. 
The great limitation in the use of the PURE system is the lack of proteins which 
could help the efficiency of protein translation30 or the complete maturation of products 
that need post-translational modification. It was shown that adding some of the major E. 
coli molecular chaperones to the in vitro PURE system reaction was enough to rescue the 
folding and to increase the production yield of many aggregation-prone cytosolic E. coli 
proteins31. Moreover, it is not ruled out the likelihood that the PURE system lacks some 
other unknown factors aiding the fully translation and folding of active globular proteins, 
leading also to a narrow temperature range of optimal operation in comparison to the 
more flexible extracts. The addition of the heterogeneous S30 E. coli crude lysate to the 
PURE system reaction was indeed observed to improve the yield and activity of 
synthesized heterologous enzymes even at lower reaction temperature when usually the 
PURE system is not quite performing32. Finally, the high expenses of using commercial 
PURE system cannot be neglected. Currently sold by New England Biolabs, 
“PURExpress In Vitro Protein Synthesis Kit” has a cost per µL 8-fold higher than 
homemade S30 E. coli Extract33. The entire protocol for reconstituting the PURE system 
in the lab has been published34 and accounts for the preparation of the >100 components 
reaction. A simpler approach was proposed by the Church lab which genetically modified 
the genome of E. coli to constitutively express a His-tagged version of all the translation 
factors and tRNA synthetases35.  
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Cell-free protein synthesis for the construction of artificial cells 
Cell-free protein synthesis is the natural starting point for any bottom-up approach to the 
creation of an artificial cell as opposed. Indeed, a large part of the essential genes believed 
to be sufficient for the sustainment of a living bacterium are involved in protein 
synthesis36. Although a completely bottom-up viable artificial cell has not yet been 
delivered, cell-free protein synthesis has successfully been performed in phospholipid 
vesicles37,38 and water-in-oil droplets39 also to establish working communication with 
natural and engineered cells40,41. In light of the key role of cell-free protein systems in 
powering the first functioning synthetic cell entities, it becomes clear how the study and 
development of these tools are essential for bottom-up reconstruction of the minimal 
cell42,43. Numerical modelling approaches has also been shown to provide a valuable 
resource for the characterization of compartmentalization efficiency44 and cell-free 
transcription-translation systems output45. 
 
Here are presented three attempts to achieve a performing in vitro protein synthesis 
system by reconstituting: a) the homemade version of the PURE, assembled according to 
Ueda’s instructions34; b) another homemade version of the PURE, prepared following 
Church’s approach35 i.e. by purifying pools of enzymes instead of performing many 
individual purifications; c) the homemade S30 E. coli Extract described by Noireaux33.  
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1.2. Results 
To obtain more flexibility on template choice and transcription-translation levels in the 
reconstituted PURE system, both T7 and E. coli RNA polymerases were purified. Indeed, 
T7 RNA polymerase is well known for its high processivity and efficiency, while E. coli 
RNA polymerase can drive transcription from a wide set of promoters with different 
levels of activity. 
T7 RNA polymerase cloning, purification and test 
T7 RNA polymerase was cloned, overexpressed and purified to drive the transcription of 
genes controlled by a T7 promoter in the homemade PURE system reaction. T7 RNA 
polymerase coding sequence and backbone were amplified by PCR using Phusion DNA 
polymerase (New England Biolabs) from TargeTron™ Vector pAR1219 (Sigma) and 
pET21b (Addgene) respectively. T7 polymerase coding sequence was cloned into 
pET21b plasmid by Gibson Assembly. His-tagged T7 RNA polymerase was 
overexpressed and purified as described in the Material and methods section. The 
presence of purified protein in the elution fractions was assessed by SDS-PAGE (Figure 
1) and fractions 8 to 13 were pooled and dialyzed against storage buffer. Purified T7 RNA 
polymerase activity was assessed by performing an in vitro transcription reaction (Figure 
2). Plasmid template used for the reaction was FC001A carrying the coding sequence of 
malachite green aptamer (MGA)44 under the transcriptional regulation of T7 promoter. 
MGA RNA folds in a secondary structure reconstituting a fluorophore. Binding to 
malachite green strongly increases the quantum yield of the fluorophore allowing for 
indirect monitoring of the transcribed RNA levels. Malachite green aptamer fluorescence 
was monitored in real time by fluorescence spectroscopy using Rotor-Gene Q 6plex 
(Qiagen).  
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Figure 1. His-tagged T7 RNA polymerase Ni++ affinity chromatography 
purification SDS-PAGE. Lane 1: PageRuler Plus Protein Ladder (Thermo Fisher 
Scientific); lane 2: flow through; lane 3: wash; lanes 4 through 15: elution fractions 5 
through 16. His-tagged T7 RNA polymerase expected mass is 100 kDa. Pooled fractions: 
8 through 13. 
 
Figure 2. T7 RNA polymerase activity test. His-tagged T7 RNA polymerase function 
was tested in an in vitro transcription reaction using FC001A plasmid as template. 
FC001A carries malachite green aptamer coding sequence under transcription 
regulation of T7 promoter. Commercial T7 RNA polymerase (New England Biolabs) was 
used as a positive control. RNA polymerase amount used in the in vitro reaction was 1/10 
of the reaction volume as recommended in commercial T7 manual.  Reactions were run 
in duplicate at 37 °C and malachite green fluorescence data was acquired with Rotor-
Gene Q 6plex (Qiagen) (excitation: 625±5 nm; emission: 660±10 nm) 
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The preparation of T7 RNA polymerase yielded a sub-homogeneous stock. The purified 
His-tagged protein seemed more efficient compared to the commercial T7 RNA 
polymerase, using the malachite green aptamer detection system. In fact, using the same 
amount of enzyme recommended by the manufacturer, fluorescence was 2-fold higher. 
E. coli RNA polymerase, σ70 purification and test 
E. coli RNA polymerase and σ70 were overexpressed and purified to be reconstituted in 
the homemade PURE system in order to drive the transcription of genes under the 
regulation of constitutive E. coli promoter or different promoters recognized by E. coli 
RNA polymerase, such as T5 promoter.  
His-tagged E. coli RNA polymerase core enzyme was prepared in three 
purification steps. First by benchtop Ni++ affinity chromatography, then by Heparin 
affinity chromatography and finally by ion-exchange chromatography using Äkta FPLC 
(GE Healthcare). SDS-PAGE was run to assess the content of elution fractions after each 
purification step. In particular elution fractions of ion-exchange chromatography are 
shown in Figure 3. 
 
Figure 3. His-tagged E. coli RNA polymerase core enzyme ion exchange 
chromatography purification SDS-PAGE. Lane 1: PageRuler Plus Protein Ladder 
(Thermo Fisher Scientific); lane 2 through 14: elution fractions 12 through 23. His-
tagged E. coli RNA polymerase subunits have expected masses of: 36.5 kDa (α), 150.6 
kDa (β), 155.1 kDa (β’), 10.2 kDa (ω). Pooled fractions: 15 through 18. 
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SDS-PAGE shows that the three purification steps allowed for a quasi-homogeneous 
preparation of E. coli RNA polymerase core enzyme.  
His-tagged σ70 transcription factor was prepared in two purification steps. First by 
benchtop Ni++ affinity chromatography then by ion-exchange chromatography using Äkta 
FPLC (GE Healthcare). SDS-PAGE was run to assess the content of elution fractions 
after each purification step. In particular elution fractions of ion-exchange 
chromatography are shown in Figure 4. 
 
Figure 4. His-tagged σ70 transcription factor ion exchange chromatography 
purification SDS-PAGE. Lane 1: PageRuler Plus Protein Ladder (Thermo Fisher 
Scientific); lanes 2 through 13: elution fractions 4 through 15. His-tagged σ70 
transcription factor has expected mass of: 36.5 kDa (α), 150.6 kDa (β), 155.1 kDa (β’), 
10.2 kDa (ω). Pooled fractions: 12 through 14. 
SDS-PAGE shows that the two purification steps yielded a sub-homogeneous 
stock of σ70 transcription factor. 
The activity of the reconstituted E. coli RNA polymerase was assessed in in vitro 
transcription reaction exploiting the malachite green aptamer detection system (Figure 5). 
Templates were two plasmids carrying the coding sequence of MGA downstream of RFP 
under the transcription regulation of the E. coli promoter pTac. One of the two plasmids 
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carries the MGA sequence located in a bigger aptamer, called pRNA, which is specifically 
designed for enhancing and protecting the structure of the hosted aptamers45. By testing 
various concentrations and combinations of the core enzyme and σ70 factor, it was 
possible to determine the best performing ratio of the core to σ70 factor to be 1:2.5. 
Optimal working concentrations are shown in Table 1. In this condition, the reconstituted 
E. coli RNA holoenzyme performed better in in vitro transcription reaction compared to 
the commercial one (Figure 5a). Moreover, the pRNA scaffold seems to increase 
transcription efficiency only in the presence of the homemade polymerase (Figure 5b).   
 
Figure 5. E. coli RNA polymerase activity test. His-tagged E. coli RNA polymerase 
holoenzyme function was tested by in vitro transcription of MGA (solid traces) and 
compared to commercial E. coli RNA polymerase (New England Biolabs) (dotted line). 
Plasmid templates used for the reaction were a) DC129A and b) GB008A. Both the 
plasmids have the E. coli constitutive promoter pTac regulating the transcription of RFP 
coding sequence followed by MGA coding sequence. Whereas DC129A features a simple 
MGA sequence, GB008A allows for the transcription of MGA as part of the pRNA 
scaffold which secondary structure was designed to improve aptamers folding.  Reactions 
were run in duplicate at 37 °C and malachite green fluorescence was monitored using 
Rotor-Gene Q 6plex (Qiagen) (excitation: 625±5 nm; emission: 660±10 nm). 
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 Mass Stock Working conc. 
E. coli RNA polymerase 
core enzyme 
~ 390 kDa [2x α, ß, ß' 
and ω] 2.3 µM 126 nM 
σ70 transcription factor ~ 70 kDa [σ] 15.6 µM 311 nM 
Table 1. E. coli RNA polymerase core enzyme reconstitution. Different 
concentrations were tested for both the core enzyme and the transcription factor. 
Reported are the working concentrations used in the in vitro transcription reaction in 
Figure 5. 
PURE factors purification 
Translation factors and tRNA synthetases were purified to reconstitute the factors mix of 
the homemade PURE system together with the purchased enzymes responsible for ATP 
regeneration. 
The His-tagged enzymatic components allowing for translation (listed in Table 2) 
i.e. tRNA synthetases (20 enzymes) and translation factors (10 enzymes) were over-
expressed in BL21 (DE3) pLysS E. coli cells (Promega) and purified using benchtop Ni++ 
affinity chromatography (Figure 6).  
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Protein full name Abbreviation Plasmid Resistance 
Methionyl-tRNA 
formyltransferase MTF  kan 
initiation factor-1 IF1  kan 
initiation factor-2 IF2  kan 
initiation factor-3 IF3  kan 
elongation factor thermo 
unstable EF-Tu  kan 
elongation factor-G EF-G  kan 
elongation factor thermo stable EF-Ts  kan 
release factor-1 RF1  kan 
release factor-3 RF3  kan 
ribosome recycling factor RRF  kan 
 
alanyl-tRNA synthetase AlaRS (D777K) pET28a kan 
cysteinyl-tRNA synthetase CysRS pET21a amp 
aspartyl-tRNA synthetase AspRS pET24a kan 
glutamyl-tRNA synthetase GluRS pET24a kan 
phenylalanyl-tRNA synthetase PheRS pET28a kan 
glycyl-tRNA synthetase GlyRS pET21a amp 
histidyl-tRNA synthetase HisRS pET21a amp 
isoleucyl-tRNA synthetase IleRS pET21a amp 
lysyl-tRNA synthetase LysRS pET3a amp 
leucyl-tRNA synthetase LeuRS pET21a amp 
methionyl-tRNA synthetase METRS pET24a kan 
asparaginyl-tRNA synthetase AsnRS pE30 amp 
prolyl-tRNA synthetase ProRS pET21a amp 
glutaminyl-tRNA synthetase GlnRS pET21a amp 
arginyl-tRNA synthetase ArgRS pET16b amp 
seryl-tRNA synthetase SerRS  kan 
threonyl-tRNA synthetase ThrRS pET28a kan 
valyl-tRNA synthetase ValRS pET21a amp 
tyrosyl-tRNA synthetase TyrRS pET20 amp 
triptophanyl-tRNA synthetase TrpRS pET21a amp 
T7 RNA polymerase T7 RNAP pET21a amp 
Table 2. PURE system purified protein components. 
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Figure 6. Purification of translation factors and tRNA synthetases.  On the left, 
the SDS-PAGES with samples from the translation factors purified stocks. From left to 
right: PageRuler Plus Protein Ladder (Thermo Fisher Scientific), IF1 (8.1 kDa), IF2 
(97.3 kDa), IF3 (20.4 kDa), EF-G (77.5 kDa), EF-Tu (43.3 kDa), EF-Ts (31 kDa), EF-
Ts from another purification (31 kDa), RF1 (39.6 kDa), RF3 (58.2 kDa), RRF (20.3 kDa), 
MTF (35 kDa). On the right, the SDS-PAGE with elution fractions samples from Glu-
rRNA synthetase (52 kDa) purification. 
In most cases, the benchtop purifications of the translation yielded a good amount 
of protein with a good grade of homogeneity. Some proteins showed a running pattern 
different from the expected one. The purified tRNA synthetases not always were 
expressed optimally, an example is Glu-tRNA synthetase as shown in Figure 6b. In some 
cases, the product of more purifications had to be pooled to reach a concentrated stock. 
Ribosomes were purified from the E. coli strain JE28. E. coli JE28 was genetically 
engineered by Sanyal and coworkers to constitutively express a His-tagged version of the 
L12 ribosomal protein. Four L12 proteins are part of the E. coli ribosome thus making 
JE28 a tetra-His-tagged ribosome producing strain. His-tagged ribosomes isolation was 
addressed with Ni++ affinity purification. Concentration of the ribosomes stock was 
assessed by absorption spectroscopy of a 100-fold diluted sample using ε = 4.055 x 107 
M-1cm-1 for 260 nm absorbance. Ribosomes stock normalized concentration was 4.9 µM, 
while A260/A280= 1.93 (1.9 is a value typical for pure ribosomes). 
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Church Factors purification 
The six protein pools were prepared to verify the possibility to reconstitute a homemade 
PURE system with a significantly faster protocol. The number of purifications to be 
carried out using this approach are 5-fold less compared to the classical PURE system 
preparation35. 
Engineered E. coli strains purifications allowed for the preparation of 6 protein 
pools. Each strain was grown and the protein pools purified by benchtop Ni++ affinity 
chromatography, being all His-tagged. The protein content of each stock was verified by 
SDS-PAGE (Figure 7). The contents of the individual pools are reported in Table 3.  
 
Figure 7. His-tagged PURE System factors pools purifications. Lane 1 PageRuler 
Plus Protein Ladder (Thermo Fisher Scientific); lane 2: IEF strain factors, lane 3: RF 
strain factors; lane 4: RS1 strain factors; lane 5: RS2 strain factors; lane 6: RS3 strain 
factors; lane 7: RS4 strain factors. 
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E. coli strain His-tagged factors 
IEF EF-Ts, EF-G, EF-Tu(a), EF-Tu(b), EF4, IF1, IF2, IF3 
RF RRF, RF1, RF2, RF3 
RS1 Ile-tRNA Synthetase, Pro-tRNA Synthetase, Cys-tRNA Synthetase, Leu-tRNA Synthetase, Gln-tRNA Synthetase, Ser-tRNA Synthetase 
RS2 
Asn-tRNA Synthetase, Tyr-tRNA Synthetase, Phe-tRNA Synthetase 
A, Phe-tRNA Synthetase B,Thr-tRNA Synthetase, Asp-tRNA 
Synthetase 
RS3 Arg-tRNA Synthetase, Met-tRNA Synthetase, Glu-tRNA Synthetase, His-tRNA Synthetase, Ala-tRNA Synthetase, Lys-tRNA Synthetase 
RS4 Met-tRNA Formyltransferase, Trp-tRNA Synthetase, Gly-tRNA Synthetase A, Gly-tRNA Synthetase B, Val-tRNA Synthetase 
Table 3. Church strains His-tagged components. The genome of each strain was 
engineered by Church and colleagues in order to constitutively express a set of His-tagged 
components. 
The purified component pools contained all the relative His-tagged proteins. A set 
of recurring unwanted bands can be observed among the pools, but the concentration of 
such protein contaminants is low and tolerable. 
Homemade PURE system (Church) reaction 
The homemade PURE system reaction was assembled by mixing the purified components 
described above with the buffer solution described above. The reaction template 
(DC032A) carried RFP coding sequence under T7 promoter transcription regulation. 
Downstream the RFP gene, the plasmid also contained the spinach aptamer46 coding 
sequence. The folded spinach aptamer can bind to the small molecule (Z)-4-(3,5-difluoro-
4-hydroxybenzylidene)-1,2-dimethyl-1H-imidazol-5(4H)-one (DFHBI). DFHBI free in 
solution has a very low quantum yield that strongly increases upon binding to spinach. 
Monitoring DFHBI fluorescence allows for the indirect quantification of the transcribed 
RNA levels (Figure 8). 
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Figure 8. Homemade PURE system in vitro expression of RFP-spinach. 
Homemade PURE reaction was templated with DC032A plasmid providing the coding 
sequences of RFP and spinach aptamer under the transcriptional regulation of T7 
promoter. Showed are real time fluorescence data relative to a) RNA and b) protein. 
Reactions were run in duplicate at 37 °C and fluorescence was monitored using Rotor-
Gene Q 6plex (Qiagen). DFHBI fluorescence was acquired with the green channel 
(excitation: 470 ± 10 nm; emission: 510 ± 5 nm). RFP fluorescence was acquired with the 
orange channel (excitation: 585±5 nm; emission: 610±5nm). 
 The homemade PURE system works well both in transcription, monitored via 
spinach aptamer binding to DFHBI (Figure 8a), and translation, observed from RFP 
production (Figure 8b). However, even though the homemade T7 RNA polymerase was 
very well performing as shown above, the whole homemade PURE reaction is not as 
efficient as the commercial one (data not shown). 
TrpR transcription regulation in the homemade PURE system (Church) 
To assess whether simple transcriptional control could be reconstituted in the homemade 
PURE system, tryptophan repressor (TrpR) activity was tested in an in vitro transcription-
translation reaction (Figure 9). Two different homemade PURE reactions were run using 
DC032A plasmid (described above) or DC076A as templates. DC076A differs from 
DC032A for the presence of the tryptophan operator sequence (trpO) downstream the T7 
promoter controlling RFP expression. Moreover, a pT7-TrpR sequence is cloned 
downstream of the RFP-spinach sequence, so that TrpR is synthesized as well. The 
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expression of RFP-spinach should be repressed in DC076A-templated reaction as a result 
of TrpR binding to trpO. 
  
Figure 9. TrpR transcriptional regulation of RFP expression in homemade 
PURE system. Homemade PURE reactions were templated by plasmid vectors DC032A 
(non-repressed, black circles) and DC076A (repressed, white circles). Showed are real-
rime fluorescence data relative to a) RNA and b) protein. DC032A has T7 promoter 
driving the expression of RFP and spinach aptamer. DC076A has in addition the pT7-
TrpR sequence and trpO element downstream the T7 promoter driving RFP expression. 
When using DC076A as template, synthesized TrpR should block transcription of RFP. 
Reactions were run in duplicate at 37 °C and fluorescence was monitored using Rotor-
Gene Q 6plex (Qiagen). DFHBI fluorescence was acquired with the green channel 
(excitation: 470 ± 10 nm; emission: 510 ± 5 nm). RFP fluorescence was acquired with the 
orange channel (excitation: 585±5 nm; emission: 610±5nm). 
Tryptophan is already present in the PURE system reaction being one of the amino 
acids provided for protein synthesis. Therefore, TrpR, once synthesized, binds the 
available tryptophan and represses RFP-spinach transcription. Repression is not total, as 
shown by the RNA traces in Figure 9a, probably because some transcription of RFP-
spinach was already started before trpR synthesis and activation. 
S30 Crude Extract preparation and transcription-translation reaction 
S30 Crude Extract yield was approximately 1 mL per liter of culture. S30 in vitro 
transcription-translation control reaction was performed using the plasmid FC045A as 
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template. The plasmid template carries RFP coding sequence behind the T5 promoter, 
recognized by endogenous E. coli RNA polymerase. 
 
Figure 10. S30 Extract in vitro synthesis of RFP. S30 cell-free protein expression 
was tested using FC045A plasmid template allowing for the E. coli RNA polymerase-
dependent expression of RFP. Reactions were run in duplicate at 37 °C and fluorescence 
was monitored using Rotor-Gene Q 6plex (Qiagen). RFP fluorescence was acquired with 
the orange channel (excitation: 585±5 nm; emission: 610±5nm).  
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1.3. Discussion 
The aim of this study was to reconstitute an in vitro transcription-translation system 
comparable to the commercially available ones to be used for synthetic biology 
applications. The classic preparation of the homemade PURE led to a non-functioning 
system. The simplified procedure for assembling the PURE led to a poorly performing 
system which activity was very low when compared to the commercial kit. The S30 E. 
coli Extract is performing the best. Moreover, the procedure to prepare the S30 Crude 
Extract is relatively quick, robust and reproducible even if not trivial and in some parts 
delicate. 
The PURE system was the most appealing among the different cell-free protein 
production platforms for many reasons. First, the PURE is by definition the most elegant 
synthetic biology approach to protein synthesis. Succeeding in mimicking protein 
synthesis with this exquisite bottom-up methodology was one of the greatest 
achievements in synthetic biology and molecular biology in general. Second, the 
commercially available PURE is very expensive. Having an unlimited resource of PURE 
system in the lab would change the way experiments are conceived, possibly in a more 
relaxed and confident manner. Last, preparing the PURE system in house could open to 
a lot of possibilities in terms of fine tuning or omitting virtually every component for the 
creation of new cell-free protein synthesis architectures. To this end, all the protein 
components for the reconstitution of the translation machinery were purified by means of 
benchtop Ni++ affinity chromatography exception made for creatine kinase, myokinase, 
nucleoside-diphosphate kinase, and pyrophosphatase. In some cases, very low 
purification yields were observed. Growth could be likely affected by the overexpression 
of enzymes with such a crucial role in E. coli metabolism. A tetra-His-tagged ribosome 
was purified as well. In the PURE system, the transcription is carried out by T7 RNA 
polymerase which coding sequence was cloned in an expression vector, added of the 6x 
Histidine tag and purified. In sight of different available choices for differential 
expression in the homemade PURE, also E. coli RNA polymerase was isolated in a 
combination of three chromatography purification steps: Ni++ affinity, heparin affinity 
and ion-exchange. The σ70 transcription factor was purified as well in two steps, by Ni++ 
affinity chromatography and ion-exchange chromatography.  
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The RNA polymerases were tested for transcription activity and compared to their 
commercial counterparts. To monitor RNA traces in real time, aptamers were used that 
bind fluorophores enhancing their quantum yield. T7 RNA polymerase performed better 
than commercial polymerase when the same amount was used for transcription, meaning 
that the purified stock was characterized by a higher U/µL count. E. coli RNA polymerase 
core enzyme and σ70 transcription factor were mixed in an in vitro transcription reaction 
to reconstitute the RNA polymerase holoenzyme. After testing different ratios between 
the two purified components, the optimal reaction concentrations observed were 126 nM 
and 311 nM for the core enzyme and the σ70 transcription factor, respectively. These 
concentrations are consistent with the fact that specific and efficient RNA synthesis from 
bacterial and phage promoters is achieved when the core enzyme is saturated with σ70 
transcription factor. Purified E. coli RNA polymerase holoenzyme was performing better 
than the commercial holoenzyme. When testing in vitro transcription with E. coli RNA 
polymerase holoenzyme, the pRNA scaffold influence on malachite green aptamer 
activity was assessed. The transcription product of pRNA is reported to fold into a 
secondary structure that increases the stability and folding of up to three aptamers inserted 
into its loops. Malachite green aptamer was cloned into one of the pRNA loops and this 
setting was compared to the simple malachite green aptamer. Results show that pRNA is 
actually enhancing the folding of malachite green aptamer even if the effect is observed 
only when considerable amounts of RNA are produced. When the homemade PURE 
system was assembled, only T7 RNA polymerase transcription activity was observed. 
Translation of reporter fluorescent protein was not detectable. This was probably due to 
one or more inactive translation factor and/or tRNA synthetase. 
The Church approach to PURE system allowed for a relative quick purification of 
the translation factors. The buffer solution was assembled and the reaction tested with a 
template for the expression of RFP-spinach aptamer. Finally, the homemade PURE 
system worked in a detectable way. A simple repression of transcription was also tested 
in the homemade PURE reaction to assess whether the system was performing as 
expected. The homemade PURE system was working but the activity was extremely low. 
Shown in this chapter is the highest activity reached by the homemade PURE system 
which is 50-fold lower than the commercial PURE. 
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 S30 E. coli Crude Extract preparation needed some time to be streamlined but 
showed to be the best approach for achieving in vitro transcription-translation. After 
several trials, a consistent yield of 1 mL of S30 Crude Extract was obtained per liter of 
starting culture. Homemade S30 reaction can yield up to 150 µg/mL of RFP.  
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1.4. Materials and Methods 
E. coli chemically competent cells preparation 
This experimental procedure was adopted for every E. coli strain used. E. coli cells were 
scraped from glycerol stock and grown o/n at 37 °C, 220 rpm. On the next day, cells were 
diluted 1:100 in 50 mL of LB and incubated again at 37 °C, 220 rpm. When OD600 nm = 
0.5 was reached, the culture was chilled on ice for 10 min. Cells were harvested by 10 
min centrifugation at 5,000 xg at 4 °C. Supernatant was discarded and the pellet re-
suspended in 15 mL of Transformation buffer and incubated on ice for 15 minutes. Cells 
were harvested and re-suspended in 4 mL of Transformation buffer. Glycerol was added 
to final concentration of 20% v/v. Competent cells were aliquoted into 100 µL aliquots, 
flash frozen with liquid nitrogen and stored at -80 °C. 
Transformation of E. coli chemically competent cells 
This experimental procedure was adopted for every E. coli strain used. Chemically 
competent E. coli cells were thawed on ice and added with 10-50 ng of plasmid DNA and 
incubated on ice for 20 min. Heat shock was performed by incubating cells at 42 °C for 
1 min. Cells were placed on ice again for 10 min. Cells were recovered by addition of 800 
µL of LB and incubation at 37 °C for 45 min, 220 rpm. 50 µL from recovered culture 
were spread onto LB agar plates added with antibiotic. 
 
Note: PURE system plasmids for the overexpression and purification of tRNA synthetases 
were provided by Professor Florian Seebeck (University of Basel) 
PURE Components purification 
Transformed BL21(DE3) pLysS (Promega) E. coli were grown o/n in LB with antibiotic 
starting from a single colony. The day after 1 L culture was started in LB with antibiotic 
by diluting the o/n culture 1:1000. When OD600 = 0.6 bacteria were induced with 1 mM 
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IPTG and grown for 4 additional hours. Cells were harvested by centrifugation at 5,000 
xg at 4 °C, 20 min. Pellets were resuspended in 100 mL PURE Resuspension buffer 
supplemented with PMSF protease inhibitor to 1 mM final concentration. Bacteria were 
lysed on ice with 8 cycles of sonication 15 seconds ON / 45 seconds OFF using Analog 
Sonifier Cell Disruptor (Branson) output 60%. Lysate was clarified by centrifugation at 
17,000 xg 4 °C, 30 min, twice and residual debris removed by 0.22 µm filtration.  
Each purification was performed with 10 mL Ni-NTA agarose matrix (QIAGEN). 
Ni-NTA agarose matrix was regenerated in between each protein purification to ensure 
the removal of contaminants and to allow the Ni++ charging on nitriloacetic acid-tagged 
agarose beads. Regeneration was performed by washing the matrix with 5 column 
volumes (cv) ddH2O, 3 cv 2% SDS, 5 cv 100% EtOH, 1 cv ddH2O, 5 cv 0.1 M EDTA pH 
8.0, 2 cv NiSO4, 3 cv ddH2O, 2 cv 6 M GuHCl 0.2 M acetic acid. 
Ni-NTA agarose matrix was equilibrated with 3 cv of PURE Resuspension buffer 
then the cleared lysate was loaded and let pass through at 4 °C. Matrix was washed with 
4 cv of PURE wash buffer. Bound His-tagged proteins were eluted with PURE elution 
buffer and 1.5 mL elution fractions were collected on ice. To assess which elution 
fractions contained the elution product 1 µL of each fraction was spotted on filter paper, 
stained with Staining solution for 5 min at r.t. and de-stained with flowing dH2O. Sample 
containing fractions were pooled, collected into 3 kDa or 10 kDa cutoff SnakeSkin™ 
Dialysis Tubing (Thermo Fisher Scientific) and dialyzed against 2 L PURE dialysis buffer 
for 2 hrs at 4 °C. Sample was dialyzed against 2 L PURE stock buffer o/n at 4 °C, split in 
1 mL aliquots and stored at -80 °C. 
PURE system cell-free protein synthesis 
PURE system DNA plasmid templates were prepared with Plasmid Mini Kit (Qiagen). 
Solution A and B were prepared according to Ueda’s directions34 with the exception that 
T7 RNA polymerase was not added to solution B. A typical 50 µL homemade PURE 
system reaction was run by mixing 25 µL solution A, 5 µL solution B, 10 nM plasmid 
template, 60 µM DFHBI when needed, 5 µL T7 RNA polymerase, 1 µL RiboLock RNase 
Inhibitor (Thermo Fisher Scientific) and water. Reaction was run at 37 °C for 2-6 hours 
		 30	
Note: The E. coli strains expressing the His-tagged PURE factors were kindly provided 
by professor George M. Church (Harvard University). 
Church Factors purification 
E. coli strains genetically modified to constitutively express the His-tagged factors 
(strains IEF, RF, RS1, RS2, RS3 and RS4) needed to reconstitute the PURE System and 
His-tagged ribosomes (strain RB1), were kindly provided by Professor George Church 
(Harvard University). Factors and ribosomes were purified according to 35. Each E. coli 
strain was grown in 5 mL LB with chloramphenicol at 30 °C, 220 rpm for 7 hours starting 
from glycerol stock. Culture was diluted 1:40 in 80 mL 2YTPG with chloramphenicol 
and grown for additional 14 h at 30 °C, 220 rpm. The whole 80 mL culture was used to 
start a 2 L 2YTPG culture with chloramphenicol and bacteria were grown at 30 °C, 220 
rpm till OD600nm = 3. Bacteria were harvested by centrifugation at 5,000 xg at 4 °C for 30 
min. 
Pellets from IEF, RF, RS1, RS2, RS3 and RS4 strains cultures were re-suspended 
in 200 mL Factors lysis buffer and lysed on ice with 8 cycles of sonication 15 seconds 
ON / 45 seconds OFF using Analog Sonifier Cell Disruptor (Branson) output 60%. Lysate 
was clarified by centrifugation at 4 °C, 17,000 xg, 30 min twice and by 0.22 µm filtration. 
Pellet from RB1 strain culture was re-suspended in 20 mL RB1 lysis buffer with 5 mL 
0.1 mm glass beads (Biospec). Bacteria were lysed once by means of FastPrep-24 bead-
beater (MP Biomedicals), velocity = 6.0 m/s, 30 sec. Lysate was cleared from cell debris 
and beads by centrifugation at 4 °C, 17,000 xg, 30 min twice and by 0.22 µm filtration. 
Following steps were performed using Cleared lysate was loaded on Ni-NTA matrix, 
previously equilibrated with 3 cv of Factors wash buffer (IEF, RF, RS1, RS2, RS3 and 
RS4 lysates) or RB1 wash buffer (RB1 lysate) and let pass through at 4 °C. Matrix was 
washed with 3 cv of Factors wash buffer or RB1 wash buffer. His-tagged factors were 
eluted with 3 cv of Factors elution buffer or RB1 elution buffer and 1,5 mL elution 
fractions were collected on ice. 1 µL from each elution fraction was spotted on filter paper 
and stained with Staining solution.  
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Sample containing fractions corresponding to IEF, RF, RS1, RS2, RS3 and RS4 
purifications were pooled and dialyzed against 2 L Factors storage buffer. Molecular 
weight cut-off of Snakeskin Dialysis tubing (Thermo Fisher Scientific) was 3K for IEF 
strain and 10K for RF, RS1, RS2, RS3, RS4. Sample containing fractions corresponding 
to RB1 purification were pooled. Ribosomes were harvested by ultracentrifugation at 4 
°C, 150,000 xg, 4 hours and resuspended in 100 µL RB1 storage buffer. Ribosomes stock 
concentration was determined by UV absorbance at 260 nm47. 
Church PURE system cell-free protein synthesis 
DNA plasmid templates were prepared with Plasmid Mini Kit (Qiagen). Cell-free protein 
synthesis reaction was mixed according to Church’s directions35. A typical Church PURE 
system reaction contained 700 µg/mL IEF, 370 µg/mL RF, 150 µg/mL RS, 550 µg/mL 
RS2, 183 µg/mL RS3, 79 µg/mL RS4, 22.3 µg/mL individual IF1, 30.9 µg/mL individual 
IF3, 20.0 µg/mL Arginyl-tRNA synthetase, 96.0 µg/mL Glycyl-tRNA synthetase, 0.1 
mM each amino acid, 0.3 mg/mL tRNA mix, 1 mM CTP and UTP, 2.5 mM GTP, 3 mM 
ATP, 20 mM creatine phosphate, 10 µg/mL folinic acid, 50 mM HEPES KOH pH 7.6, 
100 mM K-glutamate, 13 mM Mg-acetate, 2 mM spermidine, 2 mM DTT, 1x T7 RNA 
polymerase from 10x stock, 1 U/µL RiboLock RNase Inhibitor (Thermo Fisher 
Scientific), 10 nM DNA plasmid template, 1.5 µM His-tagged E. coli ribosomes or E. 
coli Ribosome (New England Biolabs), 60 µM DFHBI when needed. 
Gibson Assembly 
Forward and reverse primers were designed with a 20 base pairs complementarity to the 
sequence to be amplified. Self-dimer and hetero-dimer formation was checked online 
with the Oligoanalizer 3.1 (Integrated DNA Technologies). Lyophilized stocks were 
resuspended in DEPC water to a final concentration of 100 µM, and diluted in working 
10 µM stocks. Substrates for the cloning reaction were produced by PCR-amplification 
with Phusion DNA polymerase (Thermo Fisher Scientific) and 5’ overlapping primers 
with a melting temperature greater than 50 °C. 1% w/v agarose gel with 1 µL 50,000X 
Atlas ClearSight DNA Stain (BIOATLAS) was prepared in TAE. The electrophoretic 
chamber was filled with TAE. 5 µL of the PCR products were mixed with 6X DNA 
		 32	
Loading Dye (Thermo Fisher Scientific) to a final volume of 6 µL, and loaded on the gel. 
Amplicons size was assessed by running 4 µL of GeneRuler 1 kb Plus DNA Ladder 
(Thermo Fisher Scientific). Run was performed at a constant voltage of 120 V. The 
remaining volumes were incubated with 1 µL DpnI (NEB) for 1 h at 37 °C. Gibson 
Assembly reaction was assembled by mixing 5 µL 2X Gibson Master Mix with 75 ng 
vector and 3 molar equivalents of insert and ddH2O to a final volume of 10 µL. The 
cloning reaction was incubated for 1 h at 50 °C. 
T7 RNA polymerase cloning, overexpression and purification 
T7 RNA polymerase cloning and purification was performed according to 48 with 
modifications. T7 RNA polymerase coding sequence was amplified from pAR1219 
plasmid (Sigma). pET21b was chosen as plasmid vector. Resulting construct was named 
GB002A. NEB Express E. coli cells (New England Biolabs) were transformed with 
GB002A, grown in 2 L LB with antibiotic till OD600nm = 0.6, induced with 0.5 mM IPTG 
and grown o/n.  Cells were harvested by centrifugation at 5,000 xg at 4 °C. Cells were 
resuspended in T7 resuspension buffer, lysed on ice with 8 cycles of sonication 15 
seconds ON / 45 seconds OFF using Analog Sonifier Cell Disruptor (Branson) output 
60%. Lysate was clarified by centrifugation at 17,000 xg 4 °C, 30 min, twice and residual 
debris removed by 0.22 µm filtration.  
Ni-NTA agarose matrix was equilibrated with 3 cv of T7 Resuspension buffer 
then the cleared lysate was loaded and let pass through at 4 °C. Matrix was washed with 
4 cv of T7 wash buffer. Bound His-tagged T7 RNA polymerase was eluted with T7 
elution buffer and 1.5 mL elution fractions were collected on ice. To assess which elution 
fractions contained the elution product 1 µL of each fraction was spotted on filter paper, 
stained with Staining solution for 5 min at r.t. and de-stained with flowing dH2O. Sample 
containing fractions were pooled, collected 10 kDa cutoff SnakeSkin™ Dialysis Tubing 
(Thermo Fisher Scientific) and dialyzed against 2 L T7 stock buffer twice, for 2 hrs and 
o/n, at 4 °C. Sample was split in 1 mL aliquots and stored at -80 °C. 
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T7 RNA polymerase transcription 
Transcription reaction was always added with fresh DTT to 1 mM final concentration as 
a significant loss in activity was observed with old T7 RNA polymerase stocks, probably 
due to DTT oxidation.  A typical in vitro transcription contained 0.1 mg/mL BSA, 10 mM 
DTT, 35 mM MgCl2, 2 mM spermidine, 2 mM ATP CTP GTP UTP, 0.1 U/mL Yeast 
Pyrophosphatase Inorganic (New England Biolabs), 0.4 U/µL RiboLock RNase Inhibitor 
(Thermo Fisher Scientific), 10 ng/µL DNA plasmid template, 200 mM HEPES, pH 7.5. 
In vitro transcription reaction was supplemented with 1 µM Malachite green when 
template was coding for malachite green aptamer or 60 µM DFHBI when template was 
coding for spinach aptamer. Fluorescence levels were monitored in real time with Rotor-
Gene Q 6plex (Qiagen). 
 
Note: pVS10 and pIA586 plasmid vectors for the overexpression and purification of E. 
coli RNA polymerase and σ70 transcription factor respectively, were kindly provided by 
Vladimir Svetlov (New York University School of Medicine) and Irina Artsimovitch (Ohio 
State University). 
E. coli RNA polymerase core enzyme purification 
BL21 (DE3) pLysS E. coli cells (Promega) transformed with pVS10 vector were 
incubated in 100 mL LB with ampicillin at 37 °C, 220 rpm, o/n. Culture was diluted 1:100 
in 4 L LB with ampicillin, grown at 37 °C, 220 rpm till OD600nm = 0.75. Bacteria were 
induced with 1 mM IPTG and grown for additional 3 hours at 37 °C, 220 rpm. Bacteria 
were harvested by centrifugation at 4 °C, 6,000 x g, 30 minutes. Pellet was re-suspended 
in 100 mL E. coli RNAP lysis buffer added with 1 mM PMSF and 1 mg/mL lysozyme 
and incubated for 30 min on ice. Bacteria were lysed on ice with 8 cycles of sonication 
30 seconds ON / 2 min OFF using Analog Sonifier Cell Disruptor (Branson) output 60%. 
Lysate was clarified by centrifugation twice at 4 °C, 17,000 xg, 30 min. 
Lysate was loaded on Ni-NTA matrix previously equilibrated with 3 cv of E. coli 
RNAP lysis buffer. Matrix was washed with 20 mL E. coli RNAP Ni++ binding buffer. 
Bound protein was eluted with 10 mL E. coli RNAP Ni++ elution buffer. E. coli RNA 
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polymerase containing fractions were dialyzed overnight against 2 L of E. coli RNAP 
dialysis buffer AB5. 
The two following purifications were performed with Äkta FPLC (GE 
Healthcare). Before each purification pump was run 4 mL/min at 100% E. coli RNAP 
buffer B till conductivity stabilized around 95 mS/cm and then switched to 100% E. coli 
RNAP buffer A till conductivity stabilized around 4 mS/cm.  
For heparin affinity chromatography, flow rate was set to 1 mL/min and HiPrep 
Heparin FF 16/10 column (GE Healthcare) was connected to the instrument and 
equilibrated with 5% E. coli RNAP buffer B till conductivity stabilized around 9.5 
mS/cm. Dialyzed sample was loaded at 1 mL/min. Column was washed with 20 mL 5% 
B at 2 mL/min. Gradient 5% to 100% E. coli RNAP buffer B was applied over 200 mL 
at 1 mL/min. Protein elution was monitored by real time 280 nm absorbance reading. 
Bound protein eluted between conductivity 35 and 40 mS/cm. Fractions containing 
sample were pooled and dialyzed against 100 volumes of E. coli RNAP dialysis buffer 
AB5 at 4 °C, o/n.  
For ion exchange chromatography, flow rate was set to 1 mL/min and Mono Q 
5/50 GL column (GE Healthcare) was connected to the instrument and equilibrated with 
5% E. coli RNAP buffer B till conductivity stabilized around 9.5 mS/cm. Column was 
washed with 20 mL 5% B at 2 mL/min. Gradient 5% to 100% E. coli RNAP buffer B was 
applied over 200 mL at 1 mL/min. Protein elution was monitored by real time 280 nm 
absorbance reading. Bound protein eluted between conductivity 20 and 30 mS/cm. 
Fractions containing sample were pooled and dialyzed against 500 volumes of E. coli 
RNAP dialysis buffer AB5 at 4 °C, o/n.  
σ70 transcription factor purification 
BL21(DE3) pLysS E. coli (Promega) transformed with pIA586 were incubated in 100 
mL LB with kanamycin at 37 °C, 220 rpm, o/n. Culture was diluted 1:100 in 1 L LB + 
5% v/v glucose and kanamycin and grown at 37 °C, 220 rpm till OD600nm = 0.6. Bacteria 
were induced with 1 mM IPTG and grown for additional 4 hours at 30 °C, 220 rpm. 
Lowering the temperature is important for obtaining soluble σ70 protein. Bacteria were 
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harvested by centrifugation at 4 °C, 6,000 x g, 30 minutes. Pellet was re-suspended in 60 
mL σ70 Ni++ binding buffer. Bacteria were lysed on ice with 8 cycles of sonication 30 
seconds ON / 2 min OFF using Analog Sonifier Cell Disruptor (Branson), output 60%. 
Lysate was clarified by centrifugation twice at 4 °C, 17,000 xg, 30 min. 
Lysate was passed twice through Ni-NTA matrix previously equilibrated with 3 
cv of σ70 Ni++ binding buffer. Matrix was washed with 20 mL σ70 Ni++ binding buffer. 
Bound protein was eluted with 20 mL σ70 Ni++ elution buffer. Sample containing fractions 
were dialyzed overnight against 1 L of σ70 storage buffer at 4 °C. 
For ion exchange chromatography, flow rate was set to 1 mL/min and Mono Q 
5/50 GL column (GE Healthcare) was connected to the instrument and equilibrated with 
σ70 storage buffer till conductivity stabilized. Sample was loaded and column was washed 
with σ70 buffer A 2 mL/min. Gradient 0% to 100% σ70 buffer B was applied over 40 mL 
at 1 mL/min. Protein elution was monitored by real time 280 nm absorbance reading. 
Bound protein eluted around conductivity 40 mS/cm. Fractions containing sample were 
pooled, added with equal amount of 100% glycerol and stored at -80 °C. 
E. coli RNA polymerase holoenzyme in vitro transcription reaction 
E. coli RNA polymerase holoenzyme was reconstituted and tested in vitro by transcription 
of malachite green aptamer inserted or not on pRNA scaffold. A typical E. coli RNA 
polymerase in vitro transcription reaction contained: 1X E. coli RNA polymerase 
Reaction Buffer (New England Biolabs), 10 nM plasmid template, 0.5 mM each NTP, 
120 nM E. coli RNA polymerase core enzyme, 300 nM σ70 transcription factor, 10 µM 
malachite green. Control reaction was performed using 0.1 U/µL E. coli RNA polymerase 
Holoenzyme (New England Biolabs) instead of the purified enzyme. Malachite green 
fluorescence was monitored in real time with Rotor-Gene Q 6plex (Qiagen) fluoromiter, 
excitation 625±5 nm emission 660±10 nm. 
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Note: JE28 E. coli strain expressing the His-tagged ribosome was kindly provided by 
professor Professor Suparna Sanyal (Uppsala University, Sweden). 
His-tagged 70S ribosomes purification 
Ribosomes were purified according to Sanyal directions47. JE28 E. coli cells were scraped 
from glycerol stock and grown o/n at 37 °C, shaking. The day after, 1 L LB culture with 
kanamycin was started by diluting 1:100 the o/n culture. When OD600 = 1.0 culture was 
slowly cooled down to 4 C (this step leads to the accumulation of 70s ribosomes) and 
bacteria harvested by centrifugation at 4,000 xg, 30 min. Pellet was resuspended in 200 
mL 70S lysis buffer and lysed on ice with 4 cycles of sonication 5 seconds ON / 55 
seconds OFF using Analog Sonifier Cell Disruptor (Branson) output 60%. Lysate was 
clarified by centrifugation at 4 C 17,000 xg, 30 min. 
Ni-NTA agarose matrix was equilibrated with 3 cv of 70S lysis buffer then the 
cleared lysate was loaded and let pass through at 4 °C. Matrix was washed with 3 cv of 
70S wash buffer. His-tagged 70S ribosomes were eluted with 3 cv of 70S elution buffer 
and 1,5 mL elution fractions were collected on ice. 1 µL from each elution fraction was 
spotted on filter paper and stained with Staining solution. Sample containing fractions 
were pooled and immediately dialyzed against 300 mL of 70S lysis buffer, 4 times, to 
remove imidazole. His-tagged 70S ribosomes were harvested by ultracentrifugation at 4 
C 150,000 xg, 4 hrs. Pellet was re-suspended in Polymix buffer, split in aliquots, flash 
frozen in liquid nitrogen and stored at -80 C. Ribosomes stock concentration was assessed 
by absorption spectroscopy given ε = 4.055 x 107 M-1cm-1 for absorbance at 260 nm47. 
A260/A280 ratio was finally calculated, being 1.9 a value typical for pure ribosomes49. 
SDS-PAGE 
Gels were casted under the chemical hood. Resolving gel was added with TEMED right 
before being poured and overlaid with 100% isopropanol. After polymerization, residual 
isopropanol was removed and Stacking gel was poured on top. Every well was loaded 
with a total of 3 µg of sample approximately. Samples were mixed with SDS-PAGE 
Loading buffer under chemical hood, heated at 95 °C for 5 minutes and loaded. 2.5 µL of 
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PageRuler Prestained Protein Ladder (Thermo Fisher Scientific) was loaded. Chamber 
was filled with running buffer and the run was performed at a constant voltage of 120 V. 
Gel was stained with staining solution for 40 min, r.t. De-staining was performed in dH2O, 
shaking.  
Resolving gel  X2 gels  Stacking gel  X2 gels  
Resolving buffer  2.5 mL  Stacking buffer  410 µL 
ddH2O  3.35 mL  ddH2O  3.8 mL  
30% Acrylamide/Bis-acrylam 4 mL  30% Acrylamide/Bis-acrylamide 700 µL 
10% SDS  100 µL 10% SDS  100 µL 
10% APS  50 µL 10% APS  50 µL 
TEMED  10 µL TEMED  10 µL 
RNA agarose gel 
The electrophoretic chamber, the gel caster and the comb were cleaned with a solution of 
0.1 M NaOH for 15 min, and rinsed thoroughly with distilled water. 2% w/v agarose gel 
was prepared in TAE buffer with 0.5 µg Ethidium bromide. 2 µL of sample and 2 µL of 
RNA ladder High range (Fermentas) were mixed with 2 µL of 2x RNA Loading dye 
(Fermentas), boiled at 70 °C and loaded on the gel. Constant voltage of 120 mA was 
applied for 30 min. 
S30 Crude Extract preparation 
E. coli Rosetta 2(DE3) strain, kindly provided by Prof. Friedrich C. Simmel, was grown 
in 2xYTP media supplemented with 40 mM K2HPO4, 22 mM KH2PO4, and 34 µg/mL of 
chloramphenicol overnight at 37 °C, 220 rpm. An aliquot was diluted to OD 600nm = 0.01 
and incubated for 3.5 h at 37 °C, 220 rpm. Cells were harvested at 6,000 xg for 6 min at 
4 °C. Starting from the bacteria pellet, S30 Crude Extract was prepared according to 
Noireaux’s indications33 with the following modifications: yeast extract, tryptone, 
polyethylene glycol (PEG) 8000 Da, the 20 amino acids, Tris base were purchased from 
Sigma-Aldrich; SnakeSkinTM Dialysis Tubing was purchased from Thermo Fisher 
Scientific and used in place of Slide-A-Lyzer dialysis cassettes. The S30 Crude Extract 
final product was stored as 3-fold concentrated stock. S30 reaction energy solution and 
amino acid solution were prepared according to Noireaux’s indications33. 
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S30 in vitro protein synthesis reaction 
S30 reaction and calibration were performed according to Noireaux’s directions33 with 
the following exceptions: K-glutamate was not included since no considerable advantage 
was observed when using it; maltose was used as supplementary energy source50 and its 
working concentration was calibrated as well. A typical S30 in vitro transcription 
translation reaction contained: 1x S30 Crude Extract, 1.5 mM each amino acid, 1x energy 
solution, 11 mM maltose, 5 mM Mg-glutamate, 2% w/v PEG 8000, 60 µM DFHBI, 10 
nM circular DNA template. 10 µL reactions were run at 37 °C and fluorescence was 
monitored in real time by fluorescence spectroscopy using Rotor-Gene Q 6plex (Qiagen).  
Buffers table 
2xYTPG 16 g/L tryptone, 10 g/L yeast extract, 5 g/L NaCl, 5 g/L glucose, 3 g/L KH2PO4 6.86 g/L K2HPO4 
70S elution buffer 
20 mM Tris-HCl pH 7.6, 10 mM MgCl2, 150 mM KCl, 
30 mM NH4Cl, 1 mM PMSF, 0.5mg/mL Lysozyme, 
10 µg/mL DNAseI, 150 mM imidazole 
70S lysis buffer 
20mM Tris-HCl pH 7.6, 10mM MgCl2, 150mM KCl, 
30mM NH4Cl, 1 mM PMSF, 0.5mg/mL Lysozyme, 
10ug/mL DNAseI 
70S wash buffer 
20 mM Tris-HCl pH 7.6, 10 mM MgCl2, 150 mM KCl, 
30 mM NH4Cl, 1 mM PMSF, 0.5mg/mL Lysozyme, 
10 µg/mL DNAseI, 5 mM imidazole 
Ampicillin 100 µg/mL 
Chloramphenicol 34 µg/mL 
E. coli RNAP buffer A 50 mM Tris-HCl pH 6.9, 5% glycerol 0.5 mM EDTA pH 8.0, 1 mM DTT 
E. coli RNAP buffer B 50 mM Tris-HCl pH 6.9 5% glycerol 0.5 mM EDTA pH 8.0, 1 mM DTT, 1.5 M NaCl 
E. coli RNAP dialysis buffer 
AB5 
50 mM Tris pH 6.9, 75 mM NaCl 5% glycerol 0.5 
mM EDTA, 0.1 mM DTT 
E. coli RNAP lysis buffer 50 mM Tris-HCl pH 6.9, 500 mM NaCl 5% glycerol 
E. coli RNAP Ni++ binding 
buffer 
50 mM Tris-HCl pH 6.9, 500 mM NaCl 5% glycerol, 
20 mM Imidazole 
E. coli RNAP Ni++ elution 
buffer 
50 mM Tris-HCl pH 6.9, 500 mM NaCl 5% glycerol, 
250 mM Imidazole 
E. coli RNAP storage buffer 10 mM Tris-HCl pH 7.5, 50% glycerol, 100 mM NaCl, 0.1 mM EDTA, 0.1 mM DTT 
Factors elution buffer 
20 mM Tris-HOAc pH 7.6, 30 mM NH4Cl, 150 mM 
KCl, 150 mM NaCl, 400 mM imidazole-HOAc, pH 
7.4 
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Factors lysis buffer 
20 mM Tris-HOAc pH 7.6, 30 mM NH4Cl, 150 mM 
KCl, 150 mM NaCl, 1 mM PMSF, 6 mM β-
Mercaptoethanol 
Factors storage buffer 
20 mM Tris-HOAc pH 7.6, 30 mM NH4Cl, 150 mM 
KCl, 15 mM Mg(OAc)2, 6 mM β-
Mercaptoethanol, 10 µM GDP, 20% v/v Glycerol 
Factors wash buffer 20 mM Tris-HOAc pH 7.6, 30 mM NH4Cl, 150 mM 
KCl, 150 mM NaCl, 10 mM imidazole-HOAc (pH 7.4) 
Kanamycin 50 µg/mL 
LB 10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl 
Polymix Buffer 
5 mM NH4Cl, 95 mM KCl, 0.5 mM CaCl2, 8 mM 
putrescine, 1 mM spermidine, 5 mM KH2PO4, 1 mM 
DTT 
PURE dialysis buffer 
50 mM Hepes-KOH, pH 7.6, 100 mM potassium 
chloride, 10 mM magnesium chloride, 7 mM 2-
mercaptoethanol. Store at 4°C. 
PURE elution buffer 
50 mM Hepes-KOH, pH 7.6, 100 mM potassium 
chloride, 10 mM magnesium chloride, 500 mM 
imidazole, pH 7.6, 7 mM 2-mercaptoethanol 
PURE Resuspension buffer 
50 mM Hepes-KOH, pH 7.6, 1 M ammonium 
chloride, 10 mM magnesium chloride, 7 mM 2-
mercaptoethanol, 1 mM PMSF. 
PURE stock buffer 
50 mM Hepes-KOH, pH 7.6, 100 mM potassium 
chloride, 10 mM magnesium chloride, 30% glycerol,7 
mM 2-mercaptoethanol. Store at 4°C. 
PURE wash buffer 
50 mM Hepes-KOH, pH 7.6, 100 mM potassium 
chloride, 10 mM magnesium chloride, 20 mM 
imidazole, pH 7.6, 7 mM 2-mercaptoethanol.  
RB1 elution buffer 10 mM Tris-HOAc pH 7.6, 60 mM NH4Cl, 15 mM MgCl2, 0.5 mM EDTA, 150 mM imidazole 
RB1 lysis buffer 
10 mM Tris-HOAc pH 7.6, 60 mM NH4Cl, 15 mM 
MgCl2, 0.5 mM EDTA, 1 mM PMSF protease 
inhibitor 
RB1 storage buffer 20 mM Tris-HOAc pH 7.6, 30 mM NH4Cl, 15 mM MgCl2, 150 mM KCl 
RB1 wash buffer 10 mM Tris-HOAc pH 7.6, 60 mM NH4Cl, 15 mM MgCl2, 0.5 mM EDTA, 5 mM imidazole 
Resolving buffer 1.5 M Tris-HCl, pH 8.8 
SDS-PAGE Loading buffer 
(3X) 
 
240 mM Tris-HCl, pH 6.8, 6% w/v SDS, 30% v/v 
glycerol, 15% v/v β-mercaptoethanol, 0.06% w/v 
Bromophenol Blue 
Stacking buffer 1 M Tris-HCl, pH 6.8 
Staining solution 1% w/v Coomassie Brilliant Blue, 40% v/v methanol, 10% v/v acetic acid 
T7 elution buffer 50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 10% glycerol, 0.5 mM DTT 500mM Imidazole 
T7 resuspension buffer 50 mM sodium phosphate pH 8.0, 300 mM NaCl, 0.5 mM DTT 1mM PMFS (Proteinase inhibitor) 
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T7 stock buffer 50 mM Tris-HCl pH 7.9, 100 mM NaCl, 1 mM DTT, 0.1 mM EDTA, 0.1% Triton X-100, 50% Glycerol 
T7 wash buffer 50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 10% glycerol, 0.5 mM DTT, 20 mM imidazole 
TAE buffer 40 mM Tris-HCl, 1 mM EDTA pH 8.0, 0.1% v/v acetic acid 
Transformation buffer 10 mM Tris-HCl, pH 7.0, 50 mM CaCl2 
σ70 buffer A 50 mM Tris-HCl pH 8.0, 10% v/v glycerol, 0.1 mM EDTA, 0.1 mM DTT, 0.1 M NaCl 
σ70 buffer B 50 mM Tris-HCl pH 8.0, 10% v/v glycerol, 0.1 mM EDTA, 0.1 mM DTT, 0.5 M NaCl 
σ70 Ni++ binding buffer 20 mM Tris-HCl, pH 8.0, 5 mM Imidazole, 500 mM NaCl,1 mM PMSF 
σ70 Ni++ elution buffer 20 mM Tris-HCl, pH 8.0, 50 mM Imidazole, 500 mM NaCl,1 mM PMSF 
σ70 storage buffer 50 mM Tris-HCl pH 8.0, 10% v/v glycerol, 0.1 mM EDTA, 0.1 mM DTT 
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Chapter 2.  
Cell-free transcription is more variable than 
translation 
2.1. Introduction 
Regardless of the final application of synthetic biology, from investigating how life works 
to the development of new technologies, the exploited tools must be characterized by 
simple but stringent qualities. First, the tools must feature well known and characterized 
mechanisms. Second, the tools must allow for a predictable use in order to grant strongly 
reproducible output and results. Most of the tools used in synthetic biology fulfill these 
requirements1, although when it comes to cell-free expression systems and related 
applications, complexity increases and even a reproducible outcome cannot easily be 
predicted beforehand. This leads to the conclusion that the knowledge of protein 
expression in vivo can be transposed to in vitro systems only to certain extent. It becomes 
also clear that, even if we are dealing with one of the basic components of bottom-up 
synthetic biology, a comprehensive characterization of cell-free expression is needed.  
 The relationship between the kinetics of mRNA folding and gene expression 
involve many factors and are still not sufficiently understood2. Most likely this is due to 
the fact that the dynamics ruling the folding of mRNA can lead to very complex 
architectures, considering that some RNA molecules can even fold up into protein-like 
structures with catalytic activity3. 
 This leads to the consideration that a deeper understanding of the role that RNA 
folding plays in the translation process is needed. Despite not shedding light on the pure 
mechanisms of this proposed phenomenon, the work presented in this chapter is an 
attempt to provide stronger evidences that in vitro translation is more variable than 
transcription and that this is at least partially due to a) the higher system complexity of 
translation compared to transcription and b) the GC content and secondary structures of 
mRNA.  
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2.2. Results 
Variability of RNA and protein levels in an E. coli cell-free extract 
In our laboratory, it was shown by Fabio Chizzolini that the variability in in vitro protein 
translation is greater than the variability in mRNA transcription4. In particular, he 
expressed BFP and RFP with the PURE System behind four different T7 transcriptional 
promoters and four different ribosome binding sites, for a total of 16 combinations with 
predictable RNA and protein outputs. He observed that the relative transcriptional 
promoter strength gave predictable distributions of mRNA concentrations regardless of 
the strength of the RBS. Instead, when using different RBS sequences, the concentration 
of protein showed a poor correlation between constructs encoding RFP and BFP, for all 
four transcriptional promoters. Low coefficients of variation in mRNA levels for both 
genetic constructs were consistent with the fact that transcription with the PURE System 
relies on a single enzyme, T7 RNA Polymerase. On the other hand, the large number of 
proteins required to synthesize proteins could explain the higher coefficients of variation 
observed for translation of RFP and BFP. Moreover, the DNA template for mRNA 
transcription comes as a concentration-defined double stranded molecule usually 
characterized by a consistent structure regardless of sequence. Conversely, the mRNA 
template for protein production folds in a sequence-dependent manner into complex 
secondary and tertiary structures which would be expected to affect the efficiency of 
translation, as observed.  
 To determine whether the increased variability in translation was dependent on 
the RNA polymerase or simply the result of some features of the PURE system, the 
measurement was repeated with both T7 and E. coli transcriptional promoters and their 
corresponding RNA polymerase to drive the expression of RFP using an E. coli-based 
cell extract. mRNA levels were measured based on the fluorescence of the Spinach 
aptamer encoded downstream of the RFP in the presence of the DFHBI ligand (Figure 1). 
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Figure 1. Variability of RNA and protein levels in an E. coli cell-free extract. 
Plotted data represent the coefficient of variation of RNA and RFP (white and black bars 
respectively) for both T7 and pTac promoters for reactions run on the same day with the 
same batch of cell extract. The coefficient of variation was calculated for transcription 
after 1 h (the point of maximal RNA) and for translation after 6 h. The coefficient of 
variation was calculated over relative fluorescence intensities4. 
 The calculated coefficient of variation was 5-fold larger for translation than for 
transcription using T7 RNA polymerase and 1.9-fold larger with E. coli RNA polymerase 
(Figure 1). The coefficient of variation was 10.4-fold higher for transcription with E. coli 
RNA Polymerase than with T7 RNA Polymerase, consistent with the multi-subunits 
structure of the E. coli RNA Polymerase holoenzyme.  
Influence of RNA folding on transcription-translation 
The evidences that when dealing with in vitro transcription-translation, even of a single 
gene, the RBS sequence does not allow for predictable and consistent protein output, 
reflects a dependence on the entire sequence of the mRNA. In fact, different RNA 
sequences have the ability to fold differently. Different RNA secondary structures will be 
characterized by diverse complexities and stabilities, which will affect accessibility of the 
RBS sequence as well as the initiation of translation5, and thus ribosome density6. 
 To further investigate whether RNA folding impacted the cell-free expression of 
protein, four different genetic sequences encoding BFP were tested. The original BFP 
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sequence, codon optimized for yeast and bacteria, was re-synthesized to maintain the 
same amino acid sequence but to have maximal or minimal GC content, and an additional 
sequence codon optimized construct for expression in E. coli was synthesized. PURE 
system templates were then generated by PCR amplification of the BFP coding sequences 
using primers to introduce the same T7 promoter upstream of the RBS. mRNA 
measurements were based on the fluorescence of the Spinach aptamer coded downstream 
of the BFP. Resulting RNA and BFP protein yields are shown in Figure 2. 
 
 
Figure 2. Different GC contents of BFP coding sequence lead to differences in 
translation but not transcription. Variants of the blue fluorescent protein Azurite 
were generated with different percentages of GC content in order to probe the 
relationship between mRNA structure and protein expression in PURE system reactions. 
PURE system reactions were incubated for 6 hours at 37 °C with the different templates 
for the production of different coding sequences. Both transcription and translation were 
monitored using fluorescence. Samples tested were, from lower GC content to higher GC 
content, the following: NG046 (AT rich) (GC content: 30.4%), NG045 (original sequence) 
(GC content: 36.27%), NG047 (codon optimized sequence) (GC content: 47.14%), NG048 
(GC rich) (GC content: 59.97%)4.  
 The GC content appeared to impact the amount of synthesized protein (Figure 2b). 
Conversely, the concentration of mRNA seemed not to be affected in a clear manner 
(Figure 2a). In order to focus on the effect on translation, the protein concentration was 
divided by the mRNA concentration (Figure 3). 
		 48	
 
Figure 3. GC content of the coding sequence of BFP affects the synthesis of 
protein. The coding sequence of the protein was modified to maximize either the AT or 
GC content. Additionally, a codon-optimized version of the coding sequence was 
generated to assess the impact on translation. Each construct was expressed with the 
PURE system. The DNA constructs from lower GC content to higher GC content were 
NG046 (AT-rich, GC content: 30.4%), NG045 (original sequence, GC content: 36.3%), 
NG047 (codon-optimized, GC content: 47.1%), and NG048 (GC-rich, GC content: 60.0%). 
R2 = 0.985. Adapted from Chizzolini et al. 4 
 Protein over RNA ratios revealed a positive correlation between GC content and 
protein expression. Although the mechanism underlying this effect is yet to be elucidated, 
similar data were previously observed in vivo in Saccharomyces cerevisiae where genes 
with high protein abundance showed more stable folds of mRNA. Furthermore, folding 
strength was also observed to strongly correlate with ribosomal density on mRNA7. 
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2.3. Discussion 
Although more work is needed to determine how robust the relationship between GC 
content and protein expression is with bacterial systems, it does appear that mRNA 
folding significantly affects the expression of protein in vitro. Previous in vivo studies on 
the initiation of translation show that high protein expression may be best achieved with 
sequences characterized by low structure spanning from the RBS region8 to the first 13 
nucleotides of the coding sequence5. Together with data shown here, these findings 
suggest that the strongest translation output comes with low RBS sequences and high GC 
content across the gene. 
 To deepen the knowledge of the influence of RNA folding on protein synthesis, 
further steps should be taken. The approach of monitoring translation outputs using 
sequences with different GC content may be repeated with other reporters both with the 
PURE system and bacterial extract. Extracts contain possibly all the soluble proteins and 
enzymes found in the host they are based on. That is, the S30 E. coli-based extract could 
arguably preserve protein factors other than the minimal set required for polypeptide 
synthesis. Comparison of the two in vitro transcription systems could provide insights on 
the influence on translation efficiency of different proteins that bind both the RNA and 
the ribosome9, certainly not present in a defined system such as the PURE system. In vitro 
protein synthesis systems can also be templated with previously transcribed mRNA 
molecules resulting in un-coupled gene expression. Un-coupled gene expression has been 
shown to strongly reduce protein synthesis efficiency due to mRNA folding in absence 
of ribosomes10. According to the findings presented here, a partial recovery of efficiency 
in un-coupled gene expression should be observed by using mRNA templates with lower 
GC content and synonymous encoded information. The simplest approach to start with, 
may be to identify a limited set of candidate sequences for laboratory screening, 
exploiting informatics prediction tools involving RNA folding and gene expression 
variability11. 
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2.4. Materials and methods 
S30 Extract cell-free transcription-translation 
E. coli-based S30 Crude Extract was prepared as described in Chapter 1, Materials and 
Methods section. A typical S30 in vitro transcription translation reaction contained: 1x 
S30 Crude Extract, 1.5 mM each amino acid, 1x energy solution, 11 mM maltose, 5 mM 
Mg-glutamate, 2% (w/v) polyethylene glycol (PEG) 8000, 60 µM (Z)-4-(3,5-difluoro-4-
hydroxybenzylidene)-1,2-dimethyl-1H-imidazol-5(4H)-one (DFHBI) (Lucerna), 10 nM 
circular DNA template. 10 µL reactions were assembled on ice and run at 30 °C. 
Fluorescence was monitored in real time using a Rotor-Gene Q 6plex (Qiagen). The green 
channel was used to detect Spinach (excitation: 470 ± 10 nm; emission: 510 ± 5 nm), and 
the orange channel was used to detect RFP (excitation: 585 ± 5 nm; emission: 610 ± 5 
nm).  
PURE System cell-free transcription-translation 
Transcription-translation reactions (9 µL) with the PURExpress in vitro protein synthesis 
kit (New England Biolabs) contained 12.6 nM of linear DNA template and 4 units of 
human placenta RNase inhibitor (New England BioLabs). When needed, DFHBI was 
added to a final concentration of 60 µM. The reaction components were assembled on ice 
and the reaction was initiated by incubation at 37 °C. Reactions were monitored for 6 h 
with a Rotor-Gene Q 6plex system (Qiagen). The green channel was used to detect 
Spinach (excitation: 470 ± 10 nm; emission: 510 ± 5 nm), and the blue channel was used 
to detect BFP (excitation: 365 ± 20 nm; emission: 460 ± 20 nm). 
Protein and RNA Standard Curves  
Standard curves to translate protein fluorescence intensity into molar concentrations were 
generated by using over-expressed and purified recombinant His-tagged Azurite (BFP). 
Each His-tagged construct was purified as described previously12. Analogous standard 
curve for RNA was generated using purified RNA. The sequence encompassing 
transcriptional promoter, RBS, BFP coding sequence, and the Spinach aptamer was 
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amplified by PCR. The amplification product was run on a 1% (w/v) agarose gel, 
extracted and purified using Wizard Plus SV PCR cleanup system (Promega), and used 
as template for in vitro transcription reaction. RNA was synthesized in a 750 µL in vitro 
transcription reaction as described in Chapter 1, Materials and Methods section using 7.5 
µL of purified His-tagged T7 RNA Polymerase and 30 nM of purified PCR product as 
template. Transcribed RNA was purified using E.Z.N.A. MicroElute RNA Clean Up Kit 
(Omega Bio-tek). Different sample dilutions were loaded on a 2% (w/v) agarose gel and 
bands intensities compared to RiboRuler High Range RNA Ladder (Thermo Scientific) 
for quantification with ImageJ13. Different concentrations of transcribed RNA were 
incubated with 60 µM DHFBI to plot a standard curve for fluorescence to concentration 
conversion.  
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Chapter 3.  
Towards artificial cells networks 
3.1. Introduction 
 
Note: the artificial cells network project and the mentioned experiment are credited to 
Dario Cecchi. 
In synthetic biology, a considerable defect of artificial cells (bottom-up approach) is the 
lack of a mechanisms for self-sustainment that is instead present in engineered living cells 
(top-down approach). Besides few strategies aimed at the restoration of energy in cell-
free transcription-translation reactions1,2, artificial cells are not yet able to efficiently use 
the available resources in their environment. To overcome this issue, the establishment of 
a proof-of-concept artificial cells network is proposed for the accomplishment of a major 
task in a cascade-like signal transduction. To this end, the possibility to set 
communication pathways between different kinds of artificial cells was envisioned. Not 
only lipid vesicles but also other kinds of artificial cells are involved in the network. A 
type of artificial cells used in this network collaboration are proteinsomes. These 
structures based on protein-polymer conjugates constitute a semi-permeable membrane, 
which pore size can vary according to the modified protein used and to all those 
conditions affecting protein folding, such as temperature, pH and ionic strength. Enzymes 
can perform catalytic reactions both on the membrane and in the lumen of these 
compartments3. Simple cargo liposomes and natural engineered cells are also present in 
the network design. 
The network cascade starts with lipid-based artificial cells encapsulating a 
transcription-translation machinery, communicating with engineered E. coli bacteria 
through the quorum sensing molecule (3-oxohexanoyl)-L-homoserine lactone (3OC6-
HSL). 3OC6-HSL is one of the signaling acyl-homoserine lactones which are produced 
by specific bacterial synthases that form a covalent bond between a lactone ring derived 
from S-adenosylmethionine (SAM) and an acyl chain transferred from acyl carrier protein 
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(ACP). 3OC6-HSL is synthesized by LuxI that catalyzes the synthesis of N-(3-
Oxohexanoyl)-L-homoserine lactone in Vibrio fischeri. 3OC6-HSL binds to LuxR 
activator of transcription which drives the expression of the bioluminescence related gene 
cassette in cooperation with the bacterial RNA polymerase. 3OC6-HSL synthesized by 
the artificial cells induces engineered bacteria to synthesize and release a pore forming 
protein which in turn permeabilizes cargo liposomes encapsulating glucose. Glucose acts 
as substrate of proteinosomes made of glucose oxidase. Glucose oxidase was modified in 
in order to carry the hydrophobic polymer poly(N-isopropylacrylamide) (PNIPAAm). 
The resulting amphipathic macromolecules form Pickering emulsions around water-in-
oil droplets. These structures are stabilized by covalent crosslinking for a stable transfer 
into water phase where they can be in contact with liposomes. Proteinosomes oxidize 
glucose to gluconic acid forming hydrogen peroxide. Hydrogen peroxide kills the last 
player in the network, E. coli bacteria.  
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Figure  1. Schematic representation of artificial cells-engineered E. coli cells 
communication network. The communication network starts with lipid-based 
artificial cells (1) synthesizing and releasing 3OC6-HSL (A) to induce engineered E. coli 
(2). E. coli is transformed with two plasmids that allow the 3OC6-HSL-dependent 
synthesis and release of a pore forming protein (B). The released pore forming protein 
permeabilizes cargo liposomes (3) encapsulating glucose (C). The released glucose is 
substrate for glucose oxidase-based proteinosomes (4). The oxidation reaction leads to 
the increase of hydrogen peroxide (D), ultimately killing a second population of 
fluorescent protein expressing engineered E. coli (5). E. coli death is monitored by colony 
forming unit count. Credit: Dario Cecchi. 
Here is presented the partial characterization of the second step of the artificial 
cells-natural cells communication network (Figure 2). First, an in vitro test of liposomes 
permeabilization activity of three pore forming proteins, aHemolysin, Lysteriolisin-O and 
Perfringolysin-O is presented. Pore forming activity was tested on different liposomes to 
assess the most suited lipid ratio for the efficient encapsulation and release of a molecular 
cargo. Second, the 3OC6-HSL-induced cell death was tested. Finally, a demonstration 
that in vivo bacteria-induced liposomes permeabilization is given. 
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Figure 2. Schematic representation of the plasmid constructs for the 
engineering of the E. coli cells. E. coli bacteria depicted as image 2 in Figure 1, 
induce the permeabilization of cargo liposomes upon 3OC6-HSL induction. The inducer 
molecule is sent by upstream artificial cells. E. coli bacteria are transformed with two 
plasmids with different origin of replication and antibiotic resistance gene. On the left, 
the first construct provides information for LuxR activator constitutive production. When 
3OC6-HSL is present, LuxR activates the transcription of T7 RNA polymerase gene, 
coded behind the luxR promoter. The T7 lysozyme system is implemented to neutralize 
basal expression of T7 RNA polymerase for a tighter expression control. On the right, 
the second plasmid carries two T7 promoters driving the expression of a colicin (ColE7) 
and a pore forming protein (PFP). T7 RNA polymerase production results in the 
transcription of these two genes. The colicin is responsible for the death of bacteria and 
the resulting release of the PFP in the medium. Free PFP can reach and permeabilize 
cargo liposomes. Credit: Dario Cecchi.  
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3.2. Results 
In vitro screening of liposomes permeabilization 
In order to achieve an efficient permeabilization of cargo liposomes, different cholesterol 
contents for the membrane were screened. Liposomes were prepared with the FDEL 
technique using different POPC:cholesterol ratios but keeping the final lipid molarity. 
Dried liposomes were prepared with 80% POPC-20% cholesterol, 60% POPC-40% 
cholesterol and 40% POPC-60% cholesterol with a constant final lipid concentration of 
12 mM. Liposomes were encapsulating calcein at self-quenching concentration (80 mM) 
in order to assess membrane permeabilization by monitoring calcein fluorescence. The in 
vitro permeabilization activity of aHL, LLO and PFO was tested by synthesizing each 
pore forming protein using the homemade S30 Extract cell-free transcription-translation 
system, in presence of the calcein encapsulating liposomes. 
The plasmids used to template the reaction allowed for constitutive expression of 
LuxR activator of transcription which, in presence of 3OC6-HSL, was driving the 
expression of the pore forming protein (aHL, LLO or PFO). In this way, it was also 
possible to evaluate the performance of the LuxI/LuxR system in terms of expression 
regulation tightness in this context.  
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Figure 3. Pore forming protein-dependent in vitro liposomes permeabilization. 
S30 Extract reactions with templates for 3OC6-HSL-inducible synthesis of aHL 
(NT001A), PFO (NT002A) and PFO (DC171A) were run in presence of liposomes 
encapsulating 80 mM calcein. Each bar represents the maximum liposomes 
permeabilization observed in the corresponding reaction. Permeabilization levels were 
normalized against the ones obtained in a positive control reaction added with 0.5% 
TritonX-100 where all the liposomes were assumed to be disrupted. Shown are data of 
the experiments performed with 20% cholesterol liposomes (left), 40% cholesterol 
liposomes (center) and 60% cholesterol liposomes (right). Each S30 Extract reaction 
provided with a plasmid template for the synthesis of the pore forming proteins was 
induced with 1 µM 3OC6-HSL (black bars) or non-induced (grey bars). Non-template 
controls were run to assess background permeabilization levels (white bars). Reactions 
were run in triplicate at 30 °C and calcein fluorescence data was acquired with Rotor-
Gene Q 6plex (Qiagen) (excitation: 470 ± 10 nm; emission: 510 ± 5 nm). 
 A general correlation was observed of increased stability of liposomes (lower 
NTC permeabilization levels) with higher cholesterol content. Among the three pore 
forming proteins, PFO seems the best performing one, especially on higher cholesterol 
liposomes. Leakage in LuxI/LuxR expression regulation system was observed.  
While screening pore forming permeabilization efficiency, additional reactions 
with a template for RFP synthesis were run in duplicate with the same settings i.e. in 
presence of liposomes with different membrane compositions (POPC and 20, 40 or 60% 
Cholesterol). RFP fluorescence was measured and accounted for two controls at once. 
First, S30 Extract functioning was checked for possible biases due to the presence of 
liposomes with different membrane compositions (Figure 4). Second, the leakage of 
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calcein from liposomes was monitored. In such reactions indeed, calcein release should 
not occur as observed in the NTC reaction. 
 
 
Figure 4. Control reactions for in vitro calcein release assay. S30 Extract in vitro 
synthesis of RFP was performed in presence of calcein liposomes to verify the integrity of 
the reaction. Template used was DC044A, bearing RFP coding sequence behind E. coli 
constitutive pTac promoter. Synthesis of RFP in presence of different liposomes was 
performed alongside aHL experiment (left), LLO experiment (center) and PFO 
experiment (right). Reactions were run in duplicate at 30 °C and RFP fluorescence data 
was acquired with Rotor-Gene Q 6plex (Qiagen) (excitation: 585±5 nm; emission: 610±5 
nm). 
The S30 Extract RFP control reactions performed approximately the same 
throughout all the experiments. Therefore, the presence of different liposomes did not 
affect in vitro transcription-translation. 
E. coli 3OC6-HSL-induced death 
To test the system for the bacteria-mediated permeabilization of cargo vesicles, the first 
step of the mechanism, i.e. 3OC6-HSL-induced cell death, was assayed (Figure 5). E. coli 
cells were transformed with two plasmid constructs. The first plasmid allows for T7 RNA 
polymerase expression in a 3OC6-HSL-inducible manner and implements the pLysS 
system for neutralizing the leaky expression of the polymerase. The second plasmid has 
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two T7 promoters driving the expression of the pore forming protein and the colicin. The 
colicin accounts for the killing of bacteria and resulting release of the pore forming 
protein, which in turn is responsible for the final permeabilization of the cargo liposomes. 
The plasmids have different origin of replication to ensure correct propagation of both 
and carry different antibiotic resistance genes for the stringent selection of co-transformed 
bacteria. Bacteria were grown and induced with 3OC6-HSL. The aim of this experiment 
was to verify that bacteria were actually dying upon the addition of the inducer molecule. 
 
 
 
Figure 5. Monitoring of engineered E. coli death induced by 3OC6-HSL. 
TOP10 E. coli cells were transformed with both DC174C and DC171A plasmid vectors, 
providing information for 3OC6-HSL-dependent T7 RNA polymerase synthesis and T7 
RNA polymerase-dependent expression of PFO and the colicin, respectively. Bacteria 
were induced with either 100 nM of 1 µM 3OC6-HSL. Right after induction and 3 hours 
after induction, serial dilutions were prepared of the cultures and plated on LB plus 
antibiotic agar plates. Colonies were counted and colony forming units/mL was 
calculated for each culture. 
After 3 hours of induction the colony forming units of the non-induced control 
increases. Colony forming units count of induced cultures after 3 hours is either the same 
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as before (100 nM 3OC6-HSL) or even lower (1 µM 3OC6-HSL) meaning that most of 
the cells died upon induction.  
In vivo permeabilization of calcein vesicles 
To finally show that induced co-transformed bacteria could cause the permeabilization of 
cargo vesicles, an in vivo calcein release assay was performed. Bacteria were transformed 
with the two plasmids as described before and self-quenching concentration vesicles were 
added to the culture. After 3OC6-HSL induction, cells were incubated overnight and 
calcein fluorescence was measured on collected supernatant samples (Figure 6) 
 
Figure 6. In vivo permeabilization of calcein liposomes. TOP10 cells were 
transformed with transformed with both DC174C and DC171A plasmid vectors, 
providing information for 3OC6-HSL-dependent T7 RNA polymerase synthesis and T7 
RNA polymerase-dependent expression of PFO and the colicin, respectively. 80 mM 
calcein encapsulating liposomes were prepared and mixed with the bacterial culture. 
Culture was split and either induced (black bar) or not (white bar) with 100 nM 3OC6-
HSL. Bacteria were incubated o/n and calcein fluorescence was measured of a sample 
from the collected supernatant. Controls are represented as dotted bars. Positive control 
was the addition of 0.3% Triton X-100. Negative control was the addition of LB medium 
supplemented with dimethyl sulfoxide (DMSO) to a final concentration of 1%. DMSO 
control was  
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Induced engineered bacteria can permeabilize cargo liposomes upon inducer molecule 
induction. Addition of 3OC6-HSL induced the expression of T7 RNA polymerase which, 
in turn, drives the expression of the colicin and of the pore forming protein. Dead bacteria 
released the synthesized pore forming protein, which ultimately permeabilized calcein-
encapsulating liposomes.  
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3.3. Discussion 
The proposed approach for the creation of a communication network between artificial 
cells and engineered bacteria involves the design and characterization of each one of the 
steps depicted in Figure 1. In this work, the characterization of one step is presented. The 
step which was taken into account is the one in which engineered bacteria (Figure 1, 
element 2) are induced by 3OC6-HSL to release a pore forming protein to provoke the 
release of glucose from cargo liposomes (Figure 1, element 3).  
The permeabilization activity of three different pore forming proteins synthesized 
in vitro using the S30 Extract protein synthesis system was tested on liposomes with 
different membrane compositions to assess the best performing setting. Although the 
actual concentrations and ratios of lipids are not clearly defined in rehydrated liposomes, 
it was clear that the more cholesterol present in the membranes, the higher the activity of 
the pore forming proteins. LLO and PFO belong to the cholesterol-dependent cytolysin 
family4,5 and were expected to perform better on membranes with higher cholesterol 
content. On the other hand, αHL is reported to recognize different docking site molecules 
on eukaryotic cell surfaces like metalloproteinases, in particular  ADAM106. 
Nevertheless, cholesterol depletion has already been observed to abrogate the binding of 
αHL to host cell membranes. The proposed mechanism is that low affinity binding 
moieties can assume the role of high affinity binding sites due to their spatial arrangement 
in the membrane7. The activity of all the three pore forming proteins is visibly increased 
with higher cholesterol content with the exception of LLO which performs better on 40% 
cholesterol liposomes rather than on 60% cholesterol liposomes. It has been reported that 
pre-incubation with cholesterol can inhibit the activity of cholesterol-dependent 
cytolysins8–10. Therefore, a possible explanation of this counter intuitive effect is that 
the high concentration of cholesterol employed for the preparation of liposomes may have 
led to a certain amount of free cholesterol molecules, sufficient for the inhibition of the 
pore forming protein activity. In the particular case of LLO, too much cholesterol should 
be avoided in the preparation of liposomes. The highest permeabilization activity was 
observed when using PFO on 60% cholesterol liposomes, where the calcein release levels 
were close to the ones obtained with the addition of Triton X-100 detergent.  
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Each plasmid vector used to template the S30 in vitro cell-free protein synthesis 
enables the expression of the forming protein in a 3OC6-HSL-dependen fashion. Using 
this plasmid, it was possible to evaluate the expression regulation tightness of the 
LuxI/LuxR system. The regulation system shows a considerable leakage of expression in 
absence of the inducer molecule. The effect is more noticeable when permeabilizing 
liposomes with higher cholesterol content. The leakage in expression control was 
confirmed in vivo in the lab (data not shown) suggesting that the LuxI/LuxR system may 
not suited for achieving a tight 3OC6-HSL-inducible release of pore forming protein 
using E. coli. 
In order to achieve a better expression control, a new regulation system was 
designed by Dario Cecchi that implements T7 RNA polyemerase. The new system 
consists of two plasmid constructs. The first construct is based on the pLysS vector and 
allows for the expression of T7 RNA polymerase in a 3OC6-HSL-inducible manner. T7 
lysozyme coding sequence is present in the construct and its expression leads to the 
inhibition of basal levels of T7 RNA polymerase. The second plasmid carries the coding 
sequences of the pore forming protein and of ColE7 bacteriocin, both regulated by a 
dedicated T7 promoter (Figure 2). Here the system was tested for functioning. The chosen 
pore forming protein was PFO (highest permeabilization activity observed) and the cargo 
vesicles were prepared with 60% cholesterol (best setting for higher permeabilization). 
First, the inducible activity of ColE7 bacteriocin was tested by colony forming units 
count. Bacteria previously transformed with both the plasmids were responsive to 3OC6-
HSL induction and showed to stop their growth and die. Then, the release of pore forming 
protein and the following permeabilization of cargo vesicles was tested. Calcein was 
encapsulated in liposomes and incubated with 3OC6-HSL-responsive bacteria previously 
transformed with the two plasmid constructs and bacteria were induced to synthesize PFO 
and ColE7. Calcein was released when the bacterial culture was induced with 3OC6-HSL 
while no calcein release was observed when the inducer molecule was not added. 
These observations suggest that the system is working. It must be said that the 
bacteria-induced permeabilization of calcein vesicles did not give positive results in the 
case of time points earlier than 16 hours. This is an indication of good stability of the 
cargo vesicles which are still intact if no pore forming protein is synthesized and released 
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by bacteria. Nevertheless, concerns arise regarding the final assembly of the whole 
network. The downstream step in the communication flow involves glucose oxidase 
proteinsomes which are required to maintain their functionality until the glucose will be 
released from the cargo liposomes. Further tests must be performed to evaluate the 
stability of proteinosomes. Moreover, the presence of glucose in the network medium 
must be taken into account since it could serve as proteinosomes substrate for the 
formation of hydrogen peroxide ahead of the induced release of the liposomes-stored 
glucose.   
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3.4. Materials and methods 
Preparation of calcein liposomes 
The Freeze-Dried Empty Liposomes (FDEL)11 method involves the formation of a thin 
lipid film after the evaporation of the organic solvent where lipids are dispersed, typically 
chloroform. The film is resuspended in water to allow for the formation of vesicles 
containing multiple lipid bilayers and homogenized by mechanical stirring or extrusion. 
Vesicles are then lyophilized and later resuspended with the aqueous solution to be 
encapsulated. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 
cholesterol stocks were dissolved in chloroform to 10 mg/mL. The desired amount was 
transferred into a glass round bottom flask and chloroform was evaporated using a rotary 
evaporator (Buchi). The lipid mixtures were resuspended in distilled water to a final 
concentration of 12 mM with different molar ratios of POPC and cholesterol. Liposome 
mixtures were homogenized for 1 min with T10 basic ULTRA-TURRAX disperser set at 
power 4. The solution was split into 100 µl aliquots in 2 mL tubes, flash-frozen in liquid 
nitrogen and dehydrated overnight with a benchtop vacuum concentrator (Labconco). 
Aliquots were stored at -20°C.  
A total of 200 µL of calcein solution in water (80 mM, self-quenching 
concentration) was used to resuspend the lipid film of 4 dried liposomes stocks by 
vortexing. Resuspended liposomes were extruded 11 times through a 200 nm cut-off 
polycarbonate membrane using Mini Extruder (Avanti). Liposomes were purified from 
the non-encapsulated dye by gel filtration on a Sephadex G-50 matrix (GE Healthcare) 
using water as mobile phase.  
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Chapter 4.  
A microfluidic dialysis chip for synthetic 
biology 
4.1. Introduction 
Microfluidics 
Microfluidics is a field dealing with the design, production and application of devices or 
processes involving volumes of liquids in the nanoliter or picoliter scale. In the last couple 
of decades microfluidics is taking advantage of new microfabrication technologies 
coming from the microelectronics and semiconductor industry. Applications are many 
and diverse such as blood-cell-separation equipment, biochemical assays, protein 
crystallography, chemical synthesis, genetic analysis, production of quantum dots and 
drug screening devices through droplet-based microfluidics. The advantages of using a 
microfluidic device are to stream-line complex assay protocols and to substantially lower 
the sample volume, thus reducing reagents consumption and maximizing the amount of 
information per valuable sample. 
Although the concepts of miniaturization and parallelization usually brought to an 
advance in technology, microfluidics largely did not impact the way scientific research is 
generally done. The most likely reason why microfluidics is not widely implemented in 
every biology lab and more in general in other science fields, is that technology users 
want technology to be simple, cheap and easy. Biology researchers have more than 
enough problems to deal with by simply working in the lab and no time to spend learning 
how to make and use microfluidic devices. On the other hand, technology developers, 
especially in universities, are often not interested in solving real problems and they want 
technology to be technically cool. 
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Working at the microscale means that fluid dynamics are different from the 
macroscale ones. For instance, surface tension and capillary forces become much more 
important than gravity. Liquid flow in a microfluidic channel is laminar and convective 
mixing does not occur thus enabling predictable diffusion kinetics (laminar vs turbulent 
flow). These properties have been exploited for a variety of tasks like passively pumping 
of fluids in micro-channels, precisely patterning surfaces with different samples1, filtering 
analytes2 and forming monodisperse droplets in multiphase stream for different 
applications3. These are just a few problem examples that microfluidics attempted to 
solve. Over the years, the development of microfluidic solutions for biomedical research 
has been embraced by engineers that analyzed different materials and fabrication 
processes. 
The material the device is built with has to interact with a large amount of different 
and complex liquid samples. For this reason, in microfluidics there is an optimally suited 
material for any given tasks and there is not a single universal solution. Most of the 
devices were at the beginning fabricated with silicon4 and glass,5 using clean-room 
techniques adapted to microfluidic devices fabrication. This choice was due to 
convenience since techniques and facilities were already in place; moreover, the first 
microfluidic applications were focused largely on electrophoretic phenomena and glass 
was the best option. Although these materials were well suited for some applications, with 
microfluidics moving towards biology research, the use of glass and silicone limited the 
development and adaptation of the technology to biology research. The need for cheaper 
and more accessible materials was met by elastomeric micro-molding techniques 
developed by Bell Labs in the 1970s6 which were then applied to microfluidics and cell 
biology in the 80s7. In the early 2000s, Whitesides described a procedure that made it 
possible to design and fabricate microfluidic systems in polydimethylsiloxane (PDMS) 
in less than 24 hours8. This crucial step in microfluidics was well represented by the 
growth of the number of publications9. Also, thermoplastics such as polystyrene have 
been tested for the fabrication of microfluidic devices 8,10,11 although the use of these 
materials does not come without limitations12. Biology has a long history of polystyrene 
usage for cell culture since this thermoplastic eliminates some issues associated with 
PDMS and makes handling and packaging easier. In addition to thermoplastic materials, 
also cheap and destructible materials such as paper, wax and cloth have been tested for 
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point-of-care application in low-resource settings. The paper-based analytical devices 
(µPADs) have the advantage of being easily incinerated, making them ideal for settings 
where there is no disposal for biological samples. These devices are the expansion of 
lateral flow assays such as pregnancy strip test. Indeed, this kind of tests uses patterned 
hydrophilic cannels where the sample can passively wick through by capillary force, often 
inducing a colorimetric readout. µPADs are becoming increasingly sophisticated13 and in 
recent studies it has been shown how paper can be used as vehicle to embed, store and 
operate synthetic gene circuits in a reproducible manner by freeze drying a cell-free gene 
expression system along with DNA on a piece of paper14.  
Rather than solely relying on PDMS for device fabrication, the microfluidic 
community is moving towards alternatives that solve problems in preforming cell biology 
and diagnostic assays. However, using a different material often requires a re-thinking of 
components design. For instance, valves and pumps, often present in a PDMS device, are 
not easy to implement in thermoplastic devices and this will require creative new 
approaches from engineers to create powerful Lab-on-a-chip devices. 
PDMS 
Polydimethylsiloxane is a mineral-organic polymer that belongs to a group of compounds 
commonly referred as silicones. The formula for PDMS is CH3[Si(CH3)2O]n Si(CH3)3, 
where n is the number of repeating monomer [Si(CH3)2] units. Apart from microfluidics, 
PDMS is used as a food additive (E900), in shampoos and as antifoaming agent in 
beverages. For the fabrication of microfluidic devices, liquid PDMS is mixed with a 
cross-linking agent that renders it a hydrophobic elastomer. 
PDMS has several advantages compared to silicon and glass. First of all, the set-
up for fabricating a small number of PDMS devices is relatively cheap. Also, PDMS can 
be easily treated to turn the hydrophobic surface into a hydrophilic type of surface,15 and 
PDMS can reversibly or (in some cases) irreversibly be bonded to plastic, glass, PDMS 
itself and other materials. This is possible through plasma treatment, a process that 
changes the polymer surface chemistry and produces silanol terminations (SiOH) on 
PDMS surfaces that can then react with glass or chemical solutions. PDMS is a 
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transparent silicon, allowing for the use of microscopy to monitor the sample. Finally, 
this polymer is generally considered as biocompatible and flexible. The elasticity of 
PDMS is probably the most important quality of the material since it allows for an easy 
removal from the delicate master mold to obtain many replicates of the chip. For this 
reason, PDMS devices are considered as single-use chips, eliminating contamination 
between analyses. Furthermore, the elasticity property of PDMS allows for valving and 
actuation16. The pressure-driven deformation of the material can be exploited to clog or 
release liquid flows into two-layer microsystems. These pneumatic micro-valves were 
introduced for the first time in the 2000 almost simultaneously by Stephen’s Quake group 
in Stanford and Hosokawa and Maeda in Japan. In this way, thousands of 
micromechanical valves can be placed in a single device, enabling control over the 
biological content17. 
Despite all these beneficial properties, there are also several limitations for 
implementing the material in biomedical research. For instance, it has been shown how 
PDMS can leak un-crosslinked oligomers from the curing process into solution,18 which 
often requires additional treatments to reduce this potentially harmful effect. 
Additionally, PDMS as a hydrophobic material, can absorb small hydrophobic molecules, 
which can affect critical cell signal dynamics or impair in vitro reactions19. Furthermore, 
since PDMS is gas permeable, evaporation can occur during experiments. This can be 
detrimental for essays especially when low volumes are involved and when osmolarity 
matters20. In conclusion, PDMS is perfect for prototyping new chip design concepts; 
however, researchers have also to take into account a number of limitations and 
precautions while designing and performing experiments. 
Rapid prototyping begins with the printing of the chip design onto a transparent 
film with a high-resolution printer. This transparency is used as a mask in contact 
photolithography and a layer of resist. In this work, the masks used are made of photo-
curable epoxy, SU-8, radiated with UV light to induce polymerization of the exposed 
regions. After removing the un-polymerized photoresist, a positive relief of the design 
remains on the silicon wafer; this structure acts as a master mold for casting the PDMS 
chip. In general, the process can be repeated to obtain multilayer structures. In this case, 
the un-polymerized photoresist is not removed and a second layer of photoresist is spun 
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on top of the first. Moreover, a second mask needs to be finely aligned and then, as 
described above, the photoresist is polymerized. Finally, by dissolving the un-
polymerized photoresist it leaves multilayer channels structures. The surface of the 
resulting wafer can be treated with a silane containing fluorinated functional group to 
facilitate the PDMS slab removal. 
PDMS chips are fabricated by soft lithography using elastomeric polymer 
molding, a technique which enables rapid prototyping. This process can be carried out in 
standard laboratory conditions without the need for cleanroom facilities. Using the master 
mold, a negative relief of the structure in PDMS is made by replica molding. PDMS pre-
polymer is poured over the wafer mold, heated to 40 - 80 °C and finally, peeled off from 
the master. Channel inlets and outlets are created with a hole-puncher. The channels are 
usually sealed (reversibly or irreversibly) against a flat substrate21. This cheap and time-
saving procedure allows for the design, fabrication and testing of new channel 
configurations. This is important in the prototyping stage of designing microfluidic 
devices, since several iterations may be needed before obtaining a working design. 
Cell-free protein synthesis in microfluidics compartments 
The compartmentalization of a transcription-translation system in microfluidic chambers 
can have different final goals. For example, this approach has been proposed as a good 
tool for rapid prototyping of genetic circuits. Compartmentalized cell-free in vitro 
systems have the advantage of being completely defined, and the absence of a cell wall 
leads to an open system allowing continuous monitoring and specific adaptation of the 
reaction parameters.  
Compartmentalized transcription-translation in microfluidic systems can be 
exploited for the high-throughput production of different proteins22. This kind of device 
can significantly reduce reagent consumption compared to commercially available cell-
free protein synthesis kits and can be used as a straightforward strategy for parallelized 
high-throughput applications using standardized equipment in drug discovery. 
Microfluidic bioreactors have also been proposed to facilitate the on-demand production 
		 73	
of therapeutic proteins for medicines and biopharmaceuticals at the point-of-care. Making 
these miniature factories cell-free should simplify the process and lower costs23. 
Here is presented a variation of an existing microfluidic dialysis device that was 
prepared to run an array of cell-free protein synthesis reactions in continuous exchange 
mode in which the mechanism and mounting is based on another device developed for 
birefringence visualization in microliter samples24. The original chip allowed for the 
efficient study of phase transitions, such as crystallization and gelation24. Here, a similar 
system is exploited to build a microfluidic platform to test chemical communication 
between bacteria and between different transcription-translation systems. The 
microfluidic device is characterized by two different chip designs. The storage layer 
allows for the compartmentalization of an aqueous sample into wells separated by oil. 
The reservoir layer allows for a continuous flow of aqueous sample. The two layers are 
separated by a dialysis membrane permeable to water and small water-soluble molecules. 
To restrict the communication to a part of the storage layer wells, a Teflon foil with 
partially aligned holes was also exploited leading to the establishment of ON and OFF 
states for the storage layer wells.  
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4.2. Results 
Polypropylene chip preparation and dialysis chip mounting 
The original dialysis chip was characterized by both storage and reservoir layers made of 
PDMS. The mounting of the original sandwich dialysis chip was not trivial and required 
high concentrations and delicate touch for the correct alignment of the multiple 
components. Moreover, once reached the perfect alignment, tightening the screws in a 
slightly sub-optimal way could easily lead to uneven pressure distribution, distortion of 
the storage layer and leakage of the sample. In sight of a more accessible procedure, it 
was explored the possibility of using polypropylene in place of PDMS for the storage 
layer of the sandwich. Polypropylene is more rigid than PDMS. Therefore, polypropylene 
could lead to a device that is less distortable, thus avoiding leakage. 
Since polypropylene is a solid polymer at room temperature, a standard casting 
could not be performed like in the case of PDMS. In order to prepare a polypropylene 
chip, the plastic had to be softened by heat and put in close contact with the mold in order 
for the features to be faithfully printed on the hot plastic. In this particular case, silicon 
molds could be likely damaged by the peeling of the cooled, solid polypropylene. A 
PDMS mold was used instead. A silicon wafer mold with positive features was designed 
and used for the casting of a negative-featured PDMS chip. This acted as mold for the 
production of positive-featured final polypropylene chips (Figure 5). 
Polypropylene was obtained directly from petri dishes given the ~1 mm thickness, 
ideal for handling. The dish walls were removed with pliers, then a scalpel was used to 
carve grooves on the plastic to allow the precise cracking of the disc to finally obtain 
small squares (~2 cm x 2 cm) as shown in Figure 1.  
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Figure 1. Preparation of the plastic unit for the polypropylene chip printing. 
The polypropylene squared pieces for the chip following printing were obtained by 
cracking the bottom of a petri dish alongside scalpel-carved grooves. 
 To print the reliefs on the polypropylene, the squared unit was placed in contact 
with the feature face of the PDMS mold after both the surfaces were previously carefully 
cleaned. Two glass slides were placed over the plastic side and beneath the PDMS side. 
The resulting "cheeseburger" (where the glass slides are the bread, the plastic is the cheese 
and the PDMS is the burger) was pressed with two double clips. The glass slides ensured 
an even distribution of pressure exerted by the clips (Figure 2a and 2b). Before 
proceeding, the PDMS features were inspected with a stereo microscope to verify that 
excess pressure was not exerted by the clips. In fact, too much pressure could squeeze 
and stretch the features of the PDMS, resulting in distorted printing on the polypropylene 
(Figure 3). The apparatus was incubated on a heating plate set to 200 °C for 1 h. The 
apparatus was cooled down at room temperature and the PDMS mold peeled off the 
printed polypropylene chip (Figure 2d). 
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Figure 2. Printing of the features on the polypropylene unit. a), b) The 
polypropylene unit was pressed against the PDMS mold with double clips. Glass slides 
were used to spread the pressure on all the chip area evenly. The apparatus was 
incubated at high temperature to allow the softening of the polypropylene which adapted 
to the PDMS mold features. c), d) After cooling down, the PDMS mold was peeled 
releasing the polypropylene chip with its printed features. 
 
Figure 3. Polypropylene aberrant printing. The exertion of too much pressure when 
printing the polypropylene chip resulted in a deformation of the PDMS mold features 
which were reproduced on the plastic. Scale bar: 400 µm. 
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The features on the polypropylene chip were analyzed at the microscope to make 
sure the channels and wells have been faithfully transferred. Typical plastic chip features 
look like the ones in Figure 4. 
 
Figure 4. Features printed on polypropylene chip. Represented is a printed 
polypropylene storage chip. Features can be seen in different magnifications. Wells and 
pillars are finely reproduced on the plastic. Scale bars: 400 µm. 
 Since the polypropylene chip has a hard consistency, a different plugging 
technique was devised. The feature-free surface of the chip needs to be free of holes and 
tubing. Instead, sample has to be loaded from the side because the two layers will be 
inserted in the metal frame which will clamp them. PDMS chips are thick and soft enough 
for holes to be punched to create a sort of pipe allowing for the loading of the sample 
from a side (Figure 5). Conversely, polypropylene chips are much thinner and hard so 
that a similar approach would be impossible. Holes were punched through the 
polypropylene chips along the axis perpendicular to the chip surface. A plain PDMS slab 
was added in the sandwich with side holes to serve as loading manifold (Figure 5). 
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Figure 5. Schematic representation of PDMS and polypropylene chip 
pluggings. Both upper and lower surfaces of the chips are not accessible to the loading 
tubing due to the metal frame scaffold (black). Sample must be loaded from the side. 
PDMS chips (lower blue part) are thick and soft enough for L-shaped holes to be punched 
to produce a side-loading manifold. The loading of the polypropylene chip (grey) was 
achieved with a PDMS slab manifold (upper blue part). Arrows indicate the plugging 
holes for PFTE tubing. The Teflon foil is depicted in green. The dialysis membrane is 
depicted in orange. 
Polypropylene chip loading 
The loading process described in Materials and Methods section was tested in the new 
dialysis chip. The water sample-oil interface needs to be well defined for the correct 
loading and following separation of the sample in the wells. Phospholipids like POPC 
and egg-PC dissolved in the oil were enough to grant a sharp phase separation but when 
loading the chip with biological samples some interaction between the oil and the aqueous 
phase was observed. To address this issue, a fluorinated, synthetic, organic solvent HFE-
7500 (Novec) was used in place of mineral oil. To stabilize the interphase, a 
biocompatible surfactant was used that is the product of the coupling of oligomeric 
perfluorinated polyethers (PFPE) with polyethyleneglycol (PEG)25. Different amounts of 
surfactant in the fluorinated oil were screened to find the minimum concentration to 
achieve an effective stabilization of the oil-biological sample interface. 0.2% w/w 
fluoropolymer surfactant in HFE-7500 fluorinated oil was found to be the minimum and 
sufficient concentration (Figure 6). 
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Figure 6. Fluoropolymer surfactant stabilization of oil-sample interface. a) 0.1% 
w/w concentration of PFPE-PEG in HFE-7500 cannot provide interphase stabilization 
b) 0.2% w/w in HFE-7500 fluorinated oil is enough for sample-oil interface stabilization. 
The biological sample used was a cyan fluorescent protein (CFP). Scale bar: 400 µm. 
E. coli 3OC6 HSL in vivo communication 
In order to test the applicability of the microfluidics dialysis chip, a bacteria 
communication experiment was designed. The communication pathway chosen is the one 
regulating V. fischeri quorum sensing bioluminescence, ideal because of its simplicity. 
The sending part consists in the quorum sensing molecule synthase, LuxI. The quorum 
sensing molecule synthesized by LuxI is (3-oxohexanoyl)-L-homoserine lactone (3OC6-
HSL). 3OC6-HSL can freely trespass bacteria phospholipid membrane and wall. The 
receiving part is constituted by the activator of transcription LuxR. Upon binding to 
3OC6-HSL, LuxR can activate the transcription of genes behind the luxR promoter 
element. Moreover the LuxI/LuxR system can be reconstituted in E. coli26 by 
recombinantly expressing the components. E. coli BL21(DE3) pLysS (Promega) was 
transformed with either a plasmid carrying the LuxI synthase gene downstream of a T7 
transcriptional promoter (sending) or with a construct containing a constitutively 
expressed transcriptional promoter (tet) for E. coli RNA polymerase that drives the 
expression of the LuxR activator and a green fluorescent protein (GFP) reporter 
controlled by a luxR promoter. The sending E. coli can be induced with the galactose 
analog isopropyl β-D-1-thiogalactopyranoside (IPTG) to express LuxI and thus 
synthesize 3OC6-HSL. The receiving E. coli will constitutively produce LuxR, which 
activates the expression of GFP in the presence of 3OC6-HSL. 
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 To test the E. coli-based LuxI/LuxR system, a flow cytometry experiment was 
performed. The sending E. coli bacteria were grown and LuxI production was induced 
with IPTG. The 3OC6-HSL-containing supernatant from the culture was then used to 
induce LuxR-mediated expression of GFP reporter in a receiver E. coli. The receiver E. 
coli culture was analyzed by fluorescence-activated cell sorting (FACS) (Figure 7). 
 
Figure 7. FACS data relative to 3OC6-HSL-dependent GFP reporter 
expression in engineered E. coli (receiving culture). Supernatant from induced E. 
coli sending culture was added to the E. coli receiving culture. E. coli receiving culture 
was then incubated for 1 hour and analyzed. On the left, the result of FACS analysis of 
receiving bacteria which was added with LB medium instead, as negative control. None 
of the counts was observed as GFP expressing. On the right, the analysis of the receiving 
bacteria population added with supernatant of the sending E. coli bacteria.  Almost 100% 
of the population counts were positive for GFP expression when added with supernatant 
of 3OC6-HSL sending E. coli.  
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In chip 3OC6-HSL E. coli communication 
To verify the functionality of the dialysis chip, the 3OC6-HSL communication 
experiment was run in the two compartments divided by the dialysis membrane and 
Teflon foil. E. coli bacteria transformed with the receiving plasmid allowing for 3OC6-
HSL-dependent GFP production were loaded on the storage layer. E. coli bacteria 
transformed with the sending plasmid were induced to produce LuxI synthase and loaded 
on the reservoir layer. Some of the wells containing the receiving bacteria were not put 
in contact with the sending part by adjusting the alignment of the Teflon foil (Figure 8, 
left). 
 
Figure 8. Bacteria – bacteria 3OC6-HSL communication inside the dialysis 
chip. The dialysis chip was mounted with the Teflon foil partially aligned with the 
storage upper layer. As a result, some of the circular wells of the storage layer were not 
in contact with the lower reservoir layer because of the lack of the hole in the Teflon foil. 
BL21 (DE3) Singles E. coli bacteria transformed with the 3OC6-HSL receiving construct 
(BBa_T9002) grown till OD600 nm = 0.5 and loaded in the wells and each well was isolated 
by flushing oil. BL21 (DE3) Singles E. coli bacteria transformed with the 3OC6-HLS 
sending construct (MC002A) were grown till OD600 nm = 0.5, induced with 0.5 mM IPTG 
for 1 hour and loaded on the lower reservoir layer of the dialysis chip. Both the syringes 
flushing oil in the storage and bacteria in the reservoir were connected to syringe pumps 
(KD scientific) and flow rate of 5 µL/hour was set. Shown are pictures taken after 1 hour 
of incubation of the chip at room temperature. On the left, the bright field picture shows 
two OFF wells on top and two ON wells on the bottom. Holes in the Teflon foil can be 
seen only in the two bottom wells. On the right, the fluorescence picture shows GFP 
expressing bacteria located in the ON wells only. Scale bars: 400 µm. 
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S30 E. coli Extract 3OC6 HSL in vitro communication 
To check the feasibility of a completely cell-free version of quorum sensing 
communication in the microfluidics dialysis chip, a homemade E. coli-based S30 Extract 
in vitro transcription-translation system was used for the cell-free reconstitution of the 
3OC6-HSL sending and receiving parts. Since the S30 Extract had to be used on both the 
sides of the dialysis chip, a control reaction was run using as template the two plasmid 
vectors providing the information for both the sending part (pT7-LuxI) and the receiving 
part (pTet-LuxR; luxR promoter-GFP) (Figure 9). 
 
Figure 9. In vitro 3OC6-HSL system verification. A S30 Extract reaction was run 
using two plasmid templates MC002A (sending) and BBa_T9002 (receiving) (black 
circles). The sending template allows for the T7 RNA polymerase-driven expression of 
LuxI synthase, hence for 3OC6-HSL production. The receiving plasmid allows for E. 
coli RNA polymerase-driven expression of LuxR and LuxR-mediated expression of GFP. 
A control reaction was run with the BBa_T9002 receiving template only to assess the 
background signal (white circles). Reactions were run in duplicate at 37 °C and 
fluorescence was monitored using Rotor-Gene Q 6plex (Qiagen). GFP fluorescence was 
acquired with the green channel (excitation: 470 ± 10 nm; emission: 510 ± 5 nm).  
In chip 3OC6-HSL S30 communication 
The E. coli 3OC6-HSL communication in-chip experiment was fully reconstructed in 
vitro. S30 Extract reactions were loaded in the storage and reservoir layers and provided 
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with receiving and sending templates, respectively. Some wells containing the receiving 
reaction were not put in contact with the sending part by adjusting the alignment of the 
Teflon foil (Figure 10) 
 
Figure 10. S30 – S30 3OC6-HSL communication inside the dialysis chip. The 
dialysis chip was mounted with the Teflon foil partially aligned with the storage layer. 
As a result, some of the circular wells of the storage layer were not in contact with the 
reservoir layer. A S30 reaction was supplemented with the receiving template 
BBa_T9002 and loaded in the circular well. A S30 reaction was supplemented with the 
sending construct MC002A and loaded on the reservoir layer of the dialysis chip. A flow 
rate of 5 µL/hour was set at 25 °C.  Shown are pictures taken after 6 hours of incubation. 
Two examples of ON and OFF wells are shown right after the chip loading and the final 
timepoint. Scale bar: 400 µm.  
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4.3. Discussion 
The dialysis device described in this work is an adaptation of the one designed and 
developed by Kornreich and colleagues24. Here the dialysis device is composed by two 
microfluidic chips that differ not only in the features design but also in the material 
composition.  
PDMS was used to cast the lower layer (storage layer) while polypropylene was 
molded to create the upper layer (reservoir layer). This chapter reports the preparation 
and characterization of the polypropylene chip, while the casting of PDMS chips has 
already been shown. Polypropylene was shaped by heat incubation. The use of PDMS as 
mold is suited for two reasons. First, PDMS can tolerate high temperatures therefore it 
will not degrade in the heating step necessary for polypropylene softening and shaping. 
Second, after the cooling of the plastic, PDMS can be peeled off the polypropylene chip.  
 The aqueous sample loaded in the upper layer fills the wells of the polypropylene 
chip. By carefully adjusting the Teflon foil at the interface between the storage layer and 
the reservoir layer, it is possible to prevent some wells to be aligned with the hole in the 
foil. Such OFF-wells cannot communicate with the reservoir layer across the dialysis 
membrane in the chip. To avoid crosstalk, ON and OFF wells need to be carefully 
separated. To this end, oil is flushed behind the aqueous sample. Aqueous sample will not 
exit from the wells thanks to the small pillars design which exploits the high Laplace 
pressure of water samples. To make the process possible, a stable interface must be 
created between the aqueous sample and the oil. A fluorinated oil was used for the 
separation of the wells and a biocompatible fluorinated surfactant was found to be suited 
for the stabilization of the interface. 
 Biochemical communication among engineered E. coli bacteria was carried out in 
the dialysis chip as a proof-of-concept experiment. Likewise, the same communication 
experiment was performed in a completely cell-free manner, using a homemade 
transcription-translation system. The apparatus was therefore shown to be functional and 
suited for studies involving the diffusion of small molecules across a dialysis membrane. 
Moreover, the total volume of all the 100 nanoliter-size wells of the storage layer is 
approximately 1 µL, thus allowing the use of less resources. Chemical communication 
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carried out inside the dialysis chip can be useful for the rapid prototyping and test of 
genetic circuits or the individual characterization of uncultured microorganisms which 
growth is dependent on specific factors provided by co-existing symbionts. Such 
microorganisms fail to survive on petri dishes but could proliferate in the microfluidic 
chip wells if put in contact with the mother soup on the reservoir compartment. Proper 
dilution of the sample would ensure the statistical distribution of one cell per well. Each 
one of these different microbes would be free to exchange factors with the mother soup 
stored in the reservoir while growing in an isolated compartment and forming 
homogeneous colonies to be recovered and used for downstream analyses. 
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4.4. Materials and methods 
Note. Design of the chips and fabrication of the silicon wafer molds are procedures 
credited to and performed by Michael Heymann and Thomas Perli.  
Mask design and silicon mold fabrication 
The different layers of the chip were designed using AutoCAD software. In total, one 
storage design and four different reservoir designs were adopted.  
The storage layer is characterized by a bypass serpentine connecting 100 round 
shaped wells with diameters of 400 µm (Figure 11). This design is a two-layer layout and 
for this reason two masks are needed. The bypass channel and well heights are equal to 
the sum of the first and the second photoresists layers. The small pillar array height is 
equal to the second layer of photoresist. The files were printed on a transparency film 
using a high-resolution printer. The transparencies were used as masks for the 
photolithography. 
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Figure 11. AutoCAD designs for the storage layer. On the left, the first 
mask is presented with transparencies for the lithography of the wells and the bypass 
channel. On the right, the second mask for the lithography of the second layer of 
photoresist is shown. The second mask also contains the features for creating the pillar 
array acting as valve for retaining the water sample (light features). Scale bar = 10 mm. 
The reservoirs were simply a perfusion system characterized by four parallel 
serpentines in order to avoid collapsing of the structure (Figure 12). 
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Figure 12. AutoCAD design for the reservoir chip. A single mask was used 
for the photo-lithography of the reservoir silicon mold. The design presents four parallel 
serpentines creating a walls pattern to prevent collapse of the structure. Scale bar = 10 
mm.  
Master molds were prepared by standard photo-lithography technique in a 
cleanroom (Figure 13). For the storage layer, two different SU-8 (MicroChem) resist 
layers were applied on the silicon wafer to obtain a two-layer negative of the chip design. 
The silicon wafer was cleaned and a drop of SU-8 was applied in the middle of the silicon 
wafer and spin coating was performed following manufacturer guidelines to obtain an 
approximate height of 100 µm27. The wafer was soft baked on a hot plate at 95°C in order 
to evaporate the solvent. The SU-8 film was exposed to UV light through the mask using 
an aligning machine. A post-exposure bake was performed to selectively cross-link the 
UV-exposed portion of the film. The process was repeated to create the second layer of 
SU-8 photoresist using the second mask. Finally, the non-exposed photoresist was 
removed from the wafer by dipping into propylene glycol monomethyl ether acetate 
(PGMEA) solvent for 5 min. An extra isopropanol rinse was performed to ensure the 
complete removal of non-exposed photoresist, being non-crosslinked SU-8 insoluble in 
isopropanol and becoming visible as white mesh. 
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Figure 13. Schematic representation of the master mold fabrication protocol. 
To obtain a multilayer structure, SU-8 Coating through to Post exposure Baking steps 
are repeated using a mask for the next photoresist layer UV crosslinking28. 
PDMS chip casting and preparation 
To prepare the PDMS chips, Sylgard® 184 silicone elastomer kit (Dow Corning) was 
used. The dust was removed from the features of the silicon wafer using N2 high pressure 
flow and placed in a petri dish previously covered with aluminum foil. About 20 g of 
PDMS pre-resin and 2 g of curing agent (10% w/w) were mixed and mixed in a plastic 
beaker using a pipette tip. The resin was poured on top of the wafer and incubated in a 
vacuum desiccator. Vacuum was applied for 30 min in order to remove all of the air 
bubbles from the resin. PDMS was cured at 70 °C, 40 min. Using a scalpel, the PDMS 
slab was cut and peeled from the mold (Figure 14). Inlet and outlet holes were created 
with a biopsy puncher (World Precision Instruments). Since the PDMS layers had to be 
assembled as a sandwich, holes were created from the side.  
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Figure 14. Schematic representation of PDMS chip casting. PDMS polymer, 
mixed with curing agent, is poured on top of the silicon wafer and cured at 40-80 °C for 
40 minutes. The cured PDMS is cut and peeled off the mold, ready to use. The silicon 
wafer mold can be used for countless PDMS chip casting. 
Polypropylene chip printing and preparation 
Polypropylene is classified as a polyolefin and is a high-molecular weight hydrocarbon. 
Like all polyolefins, polypropylene is a non-toxic, non-contaminating, very inert and 
hydrophobic materials, which does not degrade in contact with biological samples. 
Moreover, polypropylene has no known solvent at room temperature. Because of these 
highly favorable features, polypropylene is virtually found in every molecular and cellular 
biology laboratory as the most common material for each kind of plasticware. 
 
Figure 15. Schematic representation of polypropylene chip preparation. The 
polypropylene chip is softened by heat and pressed against a PDMS chip that acts as 
mold and allows for the printing of the chip features on the plastic. The PDMS mold is 
casted on a reverse-featured silicon wafer. The PDMS mold can be used for several 
polypropylene chip preparations. 
A hydrophobic coating was performed for the polypropylene storage chip. After 
cleaning the chip features with tape, the surface was treated with Easytreat BC20 Mini 
corona treater (Boussey Control) for 15-30 seconds, keeping the electrode at 2 cm from 
the chip. 10 µL of a solution of 1.5 g Cytop 809M and 25 g Solv 100E (AGC Chemicals) 
were poured on top of the features. Cytop is an amorphous (non-crystalline) 
fluoropolymer that is transparent and allows for thin film coating of different surfaces. 
Cytop treatment was completed by incubation of the polypropylene chip at 70 °C, 2 hours. 
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Dialysis chip assembly 
The dialysis chip is composed of a polypropylene storage layer and a PDMS reservoir 
layer facing one another and separated by a cellulose dialysis membrane (Spectra Labs) 
and a fluorinated ethylene propylene (FEP, Teflon) foil (McMaster Carr). The Teflon foil 
is ca. 50 µm thick and acts as a wetting control layer. The foil was cut using a VLS3.50 
Versa laser cutter with 50 W Imaging Cartridge with High Power Density Focusing 
Optics (HPDFO) to obtain holes of about 200 µm in diameter. The sandwich is kept 
together by two metal frames with tightening screws. 
Before starting the assembly, all parts are cleaned: glass slides with ethanol while 
PDMS parts with adhesive tape and pressurized air. Chip inlets and outlets are connected 
with 300 µm inner diameter #30 AWG poly(tetrafluoroethylene) tubing (PTFE) tubing 
(Cole Palmer). To assemble the chip, a glass slide is placed inside one frame and the 
reservoir layer is placed in the center with features up. The dialysis membrane is hydrated 
in water and then placed on top of the reservoir chip. The FEP foil is then put on top of 
the membrane and the polypropylene storage layer is placed, features down, on top of the 
foil, paying attention to align the holes to obtain one hole in each round well. Alignment 
of polypropylene storage chip and Teflon foil is performed using a stereomicroscope. A 
glass slide followed by the second metal frame are placed on top of the layers and the 
sandwich is tightened with screws. Since PDMS is an elastomer, features can be deformed 
if the pressure is too high. On the other hand, the chip needs to be enough tightened in 
order not to have leaks.  
Storage layer loading 
The storage layer design allows for loss-free sample loading using capillary valving. 
Samples are loaded in round wells that are connected in series by a continuous serpentine 
through which one well is loaded after the other. To eliminate sample loss from channel 
dead volume, the capillary valve based “store-then-create” loading technique is 
exploited29. The chip is primed with HFE-7500 oil by flowing the oil from the chips outlet 
in order to remove air bubbles. A 100 µL gas-tight syringe with a luer-lock (SGE 
Analytical Science) is loaded with HFE-7500 oil and connected through a 18G needle to 
the PTFE tubing. The aqueous sample is then sucked into the tubing and the syringe is 
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connected to a KDS100 syringe pump (KD scientific); a flow rate of about 10 µL/h is set. 
Once the sample starts moving, the tubing is connected to the storage chip inlet. The 
surface tension at the oil-water interface between priming oil and aqueous sample resulted 
in a pressure difference across the interface. This Laplace pressure can be calculated by 
the Young-Laplace equation as 
∆𝑃 = 𝜎 1𝑅𝑥 + 1𝑅𝑦  
where Rx and Ry are the main radii of curvature and s is the surface tension of the 
interface. To minimize its energy, the oil-sample interface has to minimize its surface 
which is equivalent to maximizing its main radii of curvature at constant volume. A low 
curvature interface in a wide channel has a lower Laplace pressure then a high curvature 
interface in a narrow channel segment. Therefore, the sample plug preferentially entered 
and flowed through the wide bypass channel instead of flowing through the narrow 
capillary valve channel (green section, Fig.8). The sample plug was then followed again 
by oil, which separated the sample in the wells into independent droplets. 
Dialysis chip in vivo 3OC6-HSL sending and receiving 
BL21 (DE3) Singles (Novagen) were transformed with sending (BBa_T9002) or 
receiving (MC002A) plasmid vectors and spread onto LB agar plates supplemented with 
50 µg/mL ampicillin. Single colonies were picked and used to start overnight cultures in 
LB with 50 µg/mL ampicillin at 37 °C, 220 rpm. Overnight cultures were diluted 100-
fold in fresh LB with ampicillin and grown till OD600 nm = 0.5 at 37 °C, 220 rpm. The 
sending culture was induced with 0.5 mM IPTG and incubated 1 hour at 37 °C, 220 rpm. 
The dialysis chip was assembled with the storage layer partially aligned with the Teflon 
foil. In this way, some of the wells were located over a part of the Teflon foil lacking the 
hole and thus, the communication with the lower layer was prevented. These wells were 
supposed to constitute the negative control in which 3OC6-HSL produced by the sending 
E. coli could not reach the receiving bacteria. A sample from the receiving culture was 
loaded on a 100 µL gas-tight syringe (SGE Analytical Science) and dispensed in the 
storage upper layer through PFTE tubing connected to the syringe needle. Oil was flushed 
right after the sample to isolate the wells. Once every well was containing the sample and 
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the oil filled the channels, the oil syringe was connected to a KDS100 syringe pump (KD 
scientific) and a constant flow of 5 µL/hour was set. A sample from the sending culture 
was loaded on the lower reservoir layer with another syringe and a constant flow of 5 
µL/hour was set using another syringe pump. Images of the loaded dialysis chip were 
acquired using an inverted Primovert iLED microscope (Zeiss). 
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Conclusions and future perspectives 
The aim of this work was the reconstitution of cell-free protein synthesis systems and the 
exploration of possible applications. Despite the PURE system was reconstituted and 
showed to be working, the activity of the system was very low compared to the 
commercially available kit. The second approach for the preparation of the PURE system 
in which protein pools are obtained from engineered strains, yielded a more active cell-
free protein synthesis system. Also in this case some considerations must be taken. The 
advantage of using a protein synthesis kit reconstituted from purified components relies 
on the possibility of adjusting every single part of it. The PURE system reconstitution 
using enzymes pools instead of singularly purified proteins significantly reduces the 
amount of work but yields a less flexible system in which the concentration of specific 
components cannot be adjusted. In this sense, the second preparation is easier but the 
product lacks the fundamental characteristic of the PURE system i.e. the complete control 
over each and every one component inside the mix. The S30 E. coli cellular Extract on 
the other hand comes as a “black-box” by definition. The S30 Crude Extract is a highly 
heterogeneous mix which include among the others all the components for protein 
synthesis. Every output of this system must therefore be interpreted accordingly, also 
considering that protein expression reactions carried out with S30 Extract may better 
simulate what actually happens in living bacteria, given the presence of virtually every 
protein synthesis-related component. To improve the activity of the PURE system, a fine 
tuning of all the components should be carried out. Also, a test of activity for the tRNA 
synthetases can be introduced in order to minimize possible sources of malfunctioning of 
the system.  
 Commercial PURE system and homemade S30 Extract were used in an attempt 
to characterize the variability of transcription and translation in vitro. Evidences are 
provided suggesting that in vitro translation is more variable than transcription. The 
complexity of the process and the number of components involved in translation are 
probably the most accounting factors. In fact, variability in mRNA synthesis in S30 
Extract decreased by switching from E. coli RNA polymerase- to T7 RNA polymerase- 
driven transcription, consistent with the fact that higher grades of complexity (see E. coli 
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vs T7 RNA polymerases) are related with higher output variability. The secondary 
structures in which RNA can fold are also clearly involved in the efficiency of protein 
synthesis. Using synonymous sequences with lower GC content in the commercial PURE 
system led to a higher protein/mRNA ratio, suggesting a more efficient use of the 
available mRNA. It is important to say that the reporter gene used in this study is a 
fluorescent protein. Quantification with different methods and expression of an enzyme 
to be tested in an assay would provide significant information on how different GC 
content in the mRNA sequence could affect the protein output functionality. The 
influence of RNA folding on protein synthesis may be further investigated. The approach 
of testing the effect of GC content on translation can be extended to other proteins. To 
additionally get insights on what mediates the effect of RNA folding, the PURE system 
and the S30 Extract should always be compared. Extracts should contain every 
translation-related factor therefore divergences between the two in vitro transcription 
systems are expected. Differences may be reduced with the addition of specific factors to 
the PURE system or with the use of chaotropic agents to minimize the effect of RNA 
folding on translation. Lower GC content effect may be also investigated in un-coupled 
protein synthesis. Providing an mRNA template to cell-free expression systems leads to 
translation un-coupled with transcription. The lower efficiency of the system is thought 
to be due to secondary structures formation and resulting lower accessibility of the 
transcript for ribosomes. According to the observations presented in this work, a partial 
recovery of un-coupled translation efficiency would be expected. 
In order to characterize one of the steps of a proposed network involving artificial 
and natural cells, the activity of pore forming proteins was tested on calcein encapsulating 
liposomes. The S30 Extract was used as platform for in vitro expression of the pore 
forming proteins and at the same time, the goodness of the proposed expression regulation 
system was assessed. Among the three pore forming proteins tested, PFO is the most 
active in permeabilization. This study lacks an estimation of the encapsulation efficiency 
of the liposomes prepared. Regardless, among the different liposomes tested, the most 
suited for permeabilization are the ones with the higher cholesterol content present in the 
membrane. The expression regulation control based on the quorum sensing molecule 
3OC6-HSL is not tight enough, providing a basal level of the gene of interest even in 
absence of the inducer. Therefore, a new regulation circuit involving T7 RNA polymerase 
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was tested in vivo. E. coli bacteria transformed with the plasmid constructs could 
successfully permeabilize liposomes showing that the system is functional. 
Permeabilization was observed after overnight incubation of induced bacteria with 
liposomes. Although this result indicates a good stability of the liposomes, it also implies 
that the downstream steps of the communication network will be delayed. To eventually 
test if the complete network communication is functional, all the components have to be 
put together and the final output of the communication flow, that is the killing of a 
population of reporter-expressing E. coli bacteria, assessed. 
A microfluidic device was developed for the exchange of water-soluble small 
molecules between low volume samples across a dialysis membrane. Applications of the 
dialysis device range from testing of chemical communication to cell-free protein 
synthesis reaction prototyping. The preparation of one of the two layers of the chip was 
characterized. The chosen material was polypropylene because of its more rigid structure 
compared to PDMS. This biocompatible plastic was softened by heat and successfully 
shaped on a PDMS mold. The resulting polypropylene chip showed to be optimal for the 
dialysis chip mounting and chemical communication between two bacteria populations 
was established. Communication inside the chip involving bacteria and cell-free protein 
synthesis reactions was shown. In vitro protein synthesis in the dialysis chip may establish 
a platform for the testing of cell-free systems which are meant to be eventually 
encapsulated for the creation of communicating artificial cells. In case of artificial entities 
to natural cells communication but also if testing artificial cells to artificial cells 
communication, the dialysis device could serve as an assaying platform. In fact, the chip 
features permit a physical separation of the samples while allowing the exchange of small 
water-soluble molecules through the dialysis membrane. This setting could mimic and act 
as a compartment for the early stages of the setting of an artificial cell system in order to 
avoid the preparation of the actual cell-like compartment every time a new part has to be 
evaluated. Moreover, the device can be used to isolate and grow uncultured 
microorganisms which need the exchange of soluble factors with the members of a 
community. Eventually, homogeneous cultures could be recovered for downstream 
characterization.  
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Appendix 
Plasmid constructs table 
Name Backbone Insert 
DC032A pET21b pT7_trpO_ mRFP1_spinach 
DC076A pET21b pT7_trpO_ mRFP1_spinach _pT7_TrpR  
DC129A pET21b pTac_B0034_mRFP1_MGapt 
DC171A pET21b pT7 - lacO - PFO - T7term - pT7 - lacO - ColE7 
DC174C pACYC184 pTet - luxR - rrnBT1 - pluxR - T7RNApol - rrnBT1 - pTet - T7lysozyme 
FC001A pUC57 pT7 - MGapt 
FC045A pET21b pT5 - lacO - mRFP1 - spinach 
GB002A pET21b pT5 - lacO - 6xHis - T7RNApol 
GB008A pET21b pTac_B0034_mRFP1_pRNA with MGapt 
NT001A pET21b pT7 - lacO - aHL - T7term - pT7 - lacO - ColE7 
NT002A pET21b pT7 - lacO - LLO - T7term - pT7 - lacO - ColE7 
pVS10  pT7 - lacO - rpoA - rpoB - rpoC - 6xHis 
pIA586  pT7 - lacO - rpoD - 6xHis 
BBa_T9002  pTet - luxR - rrnBT1- pluxR - GFPmut3b 
MC002A pET21b pT7 - LuxI 
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